BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MNF, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJY, Chan FKL; Asia–Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-165.e2. [PMID: 23583432 DOI: 10.1053/j.gastro.2013.04.007] [Cited by in Crossref: 499] [Cited by in F6Publishing: 510] [Article Influence: 49.9] [Reference Citation Analysis]
Number Citing Articles
1 Pang X, Song H, Li X, Xu F, Lei B, Wang F, Xu J, Qi L, Wang L, Tan G. Transcriptomic analyses of treatment-naïve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis. J Transl Med 2023;21:30. [PMID: 36647141 DOI: 10.1186/s12967-023-03881-6] [Reference Citation Analysis]
2 Truta B, Begum F, Datta LW, Brant SR; NIDDK IBD Genetics Consortium. Inflammatory Bowel Diseases Before and After 1990. Gastro Hep Adv 2023;2:22-32. [PMID: 36686985 DOI: 10.1016/j.gastha.2022.08.001] [Reference Citation Analysis]
3 Flanagan A, Allsopp SM, O'Connor SA, Tobin J, Pretorius C, Brown IS, Bell S, Daveson AJM. High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region. Intern Med J 2022. [PMID: 36579712 DOI: 10.1111/imj.15941] [Reference Citation Analysis]
4 Liu J, Liu S, Cao H, Shi B, Li Q, Shan J, Yuan J, Lin J. Pharmacology Mechanism of Polygonum Bistorta in Treating Ulcerative Colitis Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-18. [DOI: 10.1155/2022/6461560] [Reference Citation Analysis]
5 Aniwan S, Santiago P, Loftus EV Jr, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United European Gastroenterol J 2022;10:1063-76. [PMID: 36479863 DOI: 10.1002/ueg2.12350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Su Y, Liang J, Zhang M, Zhao M, Xie X, Wang X, Pan Z, Huang S, Yan R, Wang Q, Zhou L, Luo X. Wogonin regulates colonocyte metabolism via PPARγ to inhibit Enterobacteriaceae against dextran sulfate sodium‐induced colitis in mice. Phytotherapy Research 2022. [DOI: 10.1002/ptr.7677] [Reference Citation Analysis]
7 Goren I, Sharar Fischler T, Yanai H, Pal P, Adigopula B, Pendyala S, Ganesh G, Vishnubhotla R, Rabinowitz KM, Shaham Barda E, Yadamreddy D, Godny L, Peleg N, Banerjee R, Dotan I; Indo-Israeli IBD GastroEnterology Partnership (TIIIGER). Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts. J Clin Med 2022;11. [PMID: 36498474 DOI: 10.3390/jcm11236899] [Reference Citation Analysis]
8 Zeng S, Lin Y, Guo J, Chen X, Liang Q, Zhai X, Tao J. Differential diagnosis of Crohn’s disease and intestinal tuberculosis: development and assessment of a nomogram prediction model. BMC Gastroenterol 2022;22:461. [DOI: 10.1186/s12876-022-02519-z] [Reference Citation Analysis]
9 Limbri LF, Wilson TG, Oliver MR. Prevalence of irritable bowel syndrome and functional abdominal pain disorders in children with inflammatory bowel disease in remission. JGH Open 2022;6:818-823. [DOI: 10.1002/jgh3.12791] [Reference Citation Analysis]
10 da Luz Moreira A, de Campos Lobato LF, de Lima Moreira JP, Luiz RR, Elia C, Fiocchi C, de Souza HSP. Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study. Inflamm Bowel Dis 2022;28:1696-708. [PMID: 35089325 DOI: 10.1093/ibd/izab346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kim SH, Park Y, Kim SP, Lee SH, Oh SH, Yang SK, Yoon HJ, Kim KM. Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data. Dig Dis Sci 2022;67:5079-89. [PMID: 35094250 DOI: 10.1007/s10620-021-07328-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang D, Yin H, Wang X, Wang Z, Han M, He Q, Chen J, Xian H, Zhang B, Wei X, Yang B, Pan Y, Li J. Influence of sleep disruption on inflammatory bowel disease and changes in circadian rhythm genes. Heliyon 2022;8:e11229. [PMID: 36325141 DOI: 10.1016/j.heliyon.2022.e11229] [Reference Citation Analysis]
13 Ge L, Liu S, Li S, Yang J, Hu G, Xu C, Song W. Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut–brain communications. Front Immunol 2022;13:1016578. [DOI: 10.3389/fimmu.2022.1016578] [Reference Citation Analysis]
14 Keshav N, Ammankallu R, Shashidhar, Paithankar JG, Baliga MS, Patil RK, Kudva AK, Raghu SV. Dextran sodium sulfate alters antioxidant status in the gut affecting the survival of Drosophila melanogaster. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03349-2] [Reference Citation Analysis]
15 Choi SY, Kim ES, Jeon TY, Lee YM, Lee SM, Choe BH, Choe YH, Kang B. Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics. Aliment Pharmacol Ther 2022;56:1146-56. [PMID: 35869849 DOI: 10.1111/apt.17161] [Reference Citation Analysis]
16 Zhang Y, Liu J, Han X, Jiang H, Zhang L, Hu J, Shi L, Li J. Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019. Front Public Health 2022;10:994619. [PMID: 36159285 DOI: 10.3389/fpubh.2022.994619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lim SZ, Chuah KH, Rajaram RB, Stanley K, Shahrani S, Chan WK, Ho SH, Hilmi IN, Goh KL, Mahadeva S. Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study. J Gastroenterol Hepatol 2022;37:1732-40. [PMID: 35637160 DOI: 10.1111/jgh.15905] [Reference Citation Analysis]
18 Jin EH, Han K, Lee DH, Shin CM, Lim JH, Choi YJ, Yoon K. Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location. Gastroenterology 2022;163:637-648.e2. [PMID: 35643169 DOI: 10.1053/j.gastro.2022.05.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Chen D, Lu MM, Wang JH, Ren Y, Xu LL, Cheng WX, Wang SS, Li XL, Cheng XF, Gao JG, Kalyani FS, Jin X. High-fat diet aggravates colitis via mesenteric adipose tissue derived exosome metastasis-associated lung adenocarcinoma transcript 1. World J Gastroenterol 2022; 28(29): 3838-3853 [DOI: 10.3748/wjg.v28.i29.3838] [Reference Citation Analysis]
20 Park SH, Park SH. Personalized medicine in inflammatory bowel disease: Perspectives on Asia. J Gastroenterol Hepatol 2022;37:1434-45. [PMID: 35726657 DOI: 10.1111/jgh.15919] [Reference Citation Analysis]
21 Yuan S, Li Y, Li J, Xue JC, Wang Q, Hou XT, Meng H, Nan JX, Zhang QG. Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease. Front Pharmacol 2022;13:892790. [PMID: 35873579 DOI: 10.3389/fphar.2022.892790] [Reference Citation Analysis]
22 Odeyinka O, Alhashimi R, Thoota S, Ashok T, Palyam V, Azam AT, Sange I. The Role of Capsule Endoscopy in Crohn's Disease: A Review. Cureus 2022. [DOI: 10.7759/cureus.27242] [Reference Citation Analysis]
23 Li H, Li J, Xiao T, Hu Y, Yang Y, Gu X, Jin G, Cao H, Zhou H, Yang C. Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways. Front Pharmacol 2022;13:904420. [DOI: 10.3389/fphar.2022.904420] [Reference Citation Analysis]
24 Ranjan MK, Vuyyuru SK, Kante B, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V. Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease. Int J Colorectal Dis 2022. [PMID: 35835862 DOI: 10.1007/s00384-022-04216-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 He YM, Mao R, Yuan G, Liang RM, Long JY, Ye XQ, Iacucci M, Ghosh S, Ben-Horin S, Kaplan GG, He Y, Sung JJY, Peng S, Wang HB, Chen MH. The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018. Therap Adv Gastroenterol 2022;15:17562848221102307. [PMID: 35721841 DOI: 10.1177/17562848221102307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Watanabe K, Gardiner S, Arai S. Notable gaps between patients' and physicians' perspectives on communication and disease management in Japan: multifaceted ad hoc analyses of the global Ulcerative Colitis Narrative Survey for further optimal care. Therap Adv Gastroenterol 2022;15:17562848221095372. [PMID: 35721839 DOI: 10.1177/17562848221095372] [Reference Citation Analysis]
27 Dang AK, Gonzalez DA, Kumar R, Asif S, Bali A, Anne KK, Konanur Srinivasa NK. Vinculum of Cardiovascular Disease and Inflammatory Bowel Disease: A Narrative Review. Cureus 2022. [DOI: 10.7759/cureus.26144] [Reference Citation Analysis]
28 Yao Z, Zhang B, Niu G, Yan Z, Tong X, Zou Y, Li Y, Yang M. Neutrophil Infiltration Characterized by Upregulation of S100A8, S100A9, S100A12 and CXCR2 Is Associated With the Co-Occurrence of Crohn’s Disease and Peripheral Artery Disease. Front Immunol 2022;13:896645. [DOI: 10.3389/fimmu.2022.896645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Huang C, Dong J, Cheng L, Ma H, Wang F, Feng Y, Zhang S, Li Y, Zhang D, Jin X, Xiong X, Jiang J, Wu B, Xu H, Zhang G. Alkaloids from Aconitum carmichaelii Alleviates DSS-Induced Ulcerative Colitis in Mice via MAPK/NF-κB/STAT3 Signaling Inhibition. Evid Based Complement Alternat Med 2022;2022:6257778. [PMID: 35685720 DOI: 10.1155/2022/6257778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Yao L, Chen H, Shao B, Liu J, Wang C, Zhang Z, Cao Q. Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China. Inflamm Bowel Dis 2022;28:S25-34. [PMID: 34967411 DOI: 10.1093/ibd/izab327] [Reference Citation Analysis]
31 Arkenbosch JHC, Mak JWY, Ho JCL, Beelen EMJ, Erler NS, Hoentjen F, Bodelier AGL, Dijkstra G, Romberg-Camps M, de Boer NKH, Stassen LPS, van der Meulen AE, West R, van Ruler O, van der Woude CJ, Ng SC, de Vries AC. Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West. Inflamm Bowel Dis 2022;28:S16-24. [PMID: 34969091 DOI: 10.1093/ibd/izab316] [Reference Citation Analysis]
32 Banerjee R, Pal P, Hilmi I, Ghoshal UC, Desai DC, Rahman MM, Dutta U, Mohiuddin SA, Al Mohannadi M, Philip M, Ramesh GN, Niriella MA, De Silva AP, de Silva HJ, Pisespongsa P, Limsrivilai J, Aniwan S, Nawarathne M, Fernandopulle N, Aye TT, Ni N, Al Awadhi S, Joshi N, Ngoc PTV, Kieu TV, Nguyen AD, Abdullah M, Ali E, Zeid A, Sollano JD, Saberi B, Omar M, Mohsin MN, Aftab H, Wai TM, Shastri YM, Chaudhuri S, Ahmed F, Bhatia SJ, Travis SPL; Inflammatory Bowel Disease-Emerging Nations' Consortium (IBD-ENC) study group. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium. J Gastroenterol Hepatol 2022;37:1004-15. [PMID: 35178742 DOI: 10.1111/jgh.15801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Niu M, Chen Z, Li M, Zhang X, Chen C, Rufo PA. Differentiation of Isolated Small Bowel Crohn’s Disease from Other Small Bowel Ulcerative Diseases: Clinical Features and Double-Balloon Enteroscopy Characteristics. Gastroenterology Research and Practice 2022;2022:1-13. [DOI: 10.1155/2022/5374780] [Reference Citation Analysis]
34 Zheng Y, Liang C, Li Z, Chen J, Chen Z, Jiang Y, Dong Q, Xiao Y, Fu C, Liao W, Yuan X. Study on the mechanism of Huangqin Decoction on rats with ulcerative colitis of damp-heat type base on mtDNA, TLR4, p-PI3K, p-Akt protein expression and microbiota. J Ethnopharmacol 2022;295:115356. [PMID: 35568112 DOI: 10.1016/j.jep.2022.115356] [Reference Citation Analysis]
35 Elbadry M, Nour MO, Hussien M, Ghoneem EA, Medhat MA, Shehab H, Galal S, Eltabbakh M, El-raey F, Negm M, Afify S, Abdelhamed W, Sherief A, Abdelaziz A, Abo Elkasem M, Mahrous A, Kamal G, Maher M, Abdel-hameed O, Elbasuny A, El-zayyadi I, Bassiony A, Moussa A, Bedewy E, Elfert A, El Kassas M. Clinico-Epidemiological Characteristics of Patients With Inflammatory Bowel Disease in Egypt: A Nationwide Multicenter Study. Front Med 2022;9:867293. [DOI: 10.3389/fmed.2022.867293] [Reference Citation Analysis]
36 Chen Z, Hao W, Gao C, Zhou Y, Zhang C, Zhang J, Wang R, Wang Y, Wang S. A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Hong Y, Zhao J, Chen YR, Huang ZH, Hou LD, Shen B, Xin Y. Spinal anesthesia alleviates dextran sodium sulfate-induced colitis by modulating the gut microbiota. World J Gastroenterol 2022; 28(12): 1239-1256 [DOI: 10.3748/wjg.v28.i12.1239] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Mukhopadhyay S, Saha S, Chakraborty S, Prasad P, Ghosh A, Aich P. Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approach. PLoS ONE 2022;17:e0264400. [DOI: 10.1371/journal.pone.0264400] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Selvamani S, Mehta V, Ali El Enshasy H, Thevarajoo S, El Adawi H, Zeini I, Pham K, Varzakas T, Abomoelak B. Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.02.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
40 Shamkh MAA, Sakr MA, Abd Alaty WH, Kamel SY, Eltabbakh MM, Sherief AF, Rashad H, Askar S. A decade of inflammatory bowel disease: a single center experience in Egypt. Egypt J Intern Med 2022;34. [DOI: 10.1186/s43162-022-00115-x] [Reference Citation Analysis]
41 Gutiérrez A, Zapater P, Ricart E, González-Vivó M, Gordillo J, Olivares D, Vera I, Mañosa M, Gisbert JP, Aguas M, Sánchez-Rodríguez E, Bosca-Watts M, Laredo V, Camps B, Marín-Jiménez I, Zabana Y, Martín-Arranz MD, Muñoz R, Navarro M, Sierra E, Madero L, Vela M, Pérez-Calle JL, Sainz E, Calvet X, Arias L, Morales V, Bermejo F, Fernández-Salazar L, Van Domselaar M, De Castro L, Rodríguez C, Muñoz-Villafranca C, Lorente R, Rivero M, Iglesias E, Herreros B, Busquets D, Riera J, Martínez-Montiel MP, Roldón M, Roncero O, Hinojosa E, Sierra M, Barrio J, De Francisco R, Huguet J, Merino O, Carpio D, Ginard D, Muñoz F, Piqueras M, Almela P, Argüelles-Arias F, Alcaín G, Bujanda L, Manceñido N, Lucendo AJ, Varela P, Rodríguez-Lago I, Ramos L, Sempere L, Sesé E, Barreiro-de Acosta M, Domènech E, Francés R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Front Med (Lausanne) 2022;9:823900. [PMID: 35178413 DOI: 10.3389/fmed.2022.823900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ranim A, Peoples’ Friendship University of Russia, Ramadan M, Suslina SN, Peoples’ Friendship University of Russia, Peoples’ Friendship University of Russia. Research on obtaining of a pharmaceutical substance for the complex therapy of inflammatory bowel diseases. Pharmacy and Pharmaceutical Technology 2022. [DOI: 10.33920/med-13-2202-02] [Reference Citation Analysis]
43 Maia PDDS, Baião DDS, Nanini HF, da Silva VPF, Frambach LB, Cabral IM, Pêgo B, Ribeiro BE, Pavão MSG, Paschoalin VMF, de Souza HSP, Pierucci APTR. Bioactive Compounds from Pale Ale Beer Powder Attenuate Experimental Colitis in BALB/c Mice. Molecules 2022;27:1194. [PMID: 35208981 DOI: 10.3390/molecules27041194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Li J, Liu Z, Hu P, Wen Z, Cao Q, Zou X, Chen Y, Wang Y, Zhong J, Shen X, Demuth D, Fadeeva O, Xie L, Chen J, Qian J. Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study. BMC Gastroenterol 2022;22:44. [PMID: 35120446 DOI: 10.1186/s12876-021-02074-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
45 Huang M, Li X, Fan W, Li J, Zhu L, Lei P, Wu L, Sun Q, Zou Y, Han P. Alterations of Regional Homogeneity in Crohn's Disease With Psychological Disorders: A Resting-State fMRI Study. Front Neurol 2022;13:817556. [DOI: 10.3389/fneur.2022.817556] [Reference Citation Analysis]
46 Saleem A, Zeeshan M, Hazoor F, Mustafa G. Sigmoidoscopic extent of ulcerative colitis and associated factors in Pakistani population. Pak J Med Sci 2022;38:276-80. [PMID: 35035439 DOI: 10.12669/pjms.38.1.4648] [Reference Citation Analysis]
47 Kővári B, Báthori Á, Friedman MS, Lauwers GY. Histologic Diagnosis of Inflammatory Bowel Diseases. Adv Anat Pathol 2022;29:48-61. [PMID: 34879038 DOI: 10.1097/PAP.0000000000000325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
48 Cohen NA, Silfen A, Rubin DT. Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease. Gastroenterology 2022;162:17-21. [PMID: 34562464 DOI: 10.1053/j.gastro.2021.09.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 El-sahhar S, Varga-weisz P. The gut microbiome in health and disease: Inflammatory bowel diseases. Advances in Ecological Research 2022. [DOI: 10.1016/bs.aecr.2022.09.005] [Reference Citation Analysis]
50 Vig T, Das P, Sakhuja P, Gaur K, Majumdar K, Pulimood A. Pathology of Inflammatory Bowel Diseases and Its Mimickers, Immunodeficiency and Vascular Gastrointestinal Lesions, and Drug-Induced Bowel Pathologies. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_12] [Reference Citation Analysis]
51 Kumar S, Kumar A. Microbial pathogenesis in inflammatory bowel diseases. Microb Pathog 2021;163:105383. [PMID: 34974120 DOI: 10.1016/j.micpath.2021.105383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
52 Wei LY, Zhang JK, Zheng L, Chen Y. The functional role of sulforaphane in intestinal inflammation: a review. Food Funct 2021. [PMID: 34935814 DOI: 10.1039/d1fo03398k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Magalhães HIR, Castelucci P. Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor. World J Gastroenterol 2021; 27(46): 7909-7924 [DOI: 10.3748/wjg.v27.i46.7909] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Xu D, Zhang H, Chen Y. Patients' views of shared decision making in inflammatory bowel disease: a survey in China. BMC Med Inform Decis Mak 2021;21:340. [PMID: 34872536 DOI: 10.1186/s12911-021-01702-8] [Reference Citation Analysis]
55 Aniwan S, Loftus EV. The Natural History of Inflammatory Bowel Disease. Curr Treat Options Gastro 2021;19:597-607. [DOI: 10.1007/s11938-021-00363-w] [Reference Citation Analysis]
56 Li T, Gao L, Cao L, Guo Z, Qian W, Yin Y, Li Y, Zhu W. Changes in disease behaviour and location and factor analysis in patients with Crohn's disease undergoing repeated-resections. Eur J Gastroenterol Hepatol 2021;33:e555-63. [PMID: 33852510 DOI: 10.1097/MEG.0000000000002145] [Reference Citation Analysis]
57 Yewale RV, Natarajan K, Ubal Dhus J, Parameswaran SA, Ramaswamy Palaniswamy K, Babu Vinish D, Somasundaram A, Ramakrishnan A, Karmegam S, Arun RS, Manmohan US, Mahadevan B, Harri Prasad B, Chandrasekar TS, Gokul BJ, Dutta A, Joseph AJ, Venkatraman J, Ganesh P, Shanmuganathan S, Alagammai PL, Ramasubramanian R, Venkatakrishnan L, Ganesan R, Chandrasekaran Arun A, Srinivas S, Kannan M, Revathy MS, Sathiyasekaran M, Sarangapani A, Rajesh N, Arulselvan V, Aravind A, Premkumar K, Kavitha S, Varadarajulu HV, Manimaran M, Basumani P, Murali A, Ramakrishna BS. Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices. JGH Open 2021;5:1306-13. [PMID: 34816017 DOI: 10.1002/jgh3.12673] [Reference Citation Analysis]
58 Cui G, Liu H, Xu G, Laugsand JB, Pang Z. Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:757025. [PMID: 34778319 DOI: 10.3389/fmed.2021.757025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Johnson AM, Harmsen WS, Aniwan S, Tremaine WJ, Abu Dayyeh BK, Loftus EV. Prevalence and Impact of Obesity on Disease-specific Outcomes in a Population-based Cohort of Patients with Ulcerative Colitis. J Crohns Colitis 2021;15:1816-23. [PMID: 34117877 DOI: 10.1093/ecco-jcc/jjab097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Jung S, Ye BD, Lee HS, Baek J, Kim G, Park D, Park SH, Yang SK, Han B, Liu J, Song K. Identification of Three Novel Susceptibility Loci for Inflammatory Bowel Disease in Koreans in an Extended Genome-Wide Association Study. J Crohns Colitis 2021;15:1898-907. [PMID: 33853113 DOI: 10.1093/ecco-jcc/jjab060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Mosli M, Alawadhi S, Hasan F, Abou Rached A, Sanai F, Danese S. Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis. Inflamm Intest Dis 2021;6:123-31. [PMID: 34722642 DOI: 10.1159/000518003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
62 Chen S, Chen Z, Wang Y, Hao W, Yuan Q, Zhou H, Gao C, Wang Y, Wu X, Wang S. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
63 Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev 2021;42:1603990. [PMID: 34692176 DOI: 10.3389/phrs.2021.1603990] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
64 Xiao-qing D, Xiao-ying L, Xue-jun W, Xiao-cong G, Jun-yi L, Yun-qiong L, Li L, Jia-ni C, Dan Z, Yuan L, Huan-gan W, Chen X, Xiao-peng M. Study on the regulatory effect of herbal cake-partitioned moxibustion on colonic CD206, AMPK and TSC2 in rats with Crohn disease. J Acupunct Tuina Sci 2021;19:329-37. [DOI: 10.1007/s11726-021-1263-7] [Reference Citation Analysis]
65 Jaaouani A, Ismaiel A, Popa SL, Dumitrascu DL. Acute Coronary Syndromes and Inflammatory Bowel Disease: The Gut-Heart Connection. J Clin Med 2021;10:4710. [PMID: 34682835 DOI: 10.3390/jcm10204710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 Liu M, Yuan W, Park S. Association between IL-10 rs3024505 and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis. Cytokine 2022;149:155721. [PMID: 34628128 DOI: 10.1016/j.cyto.2021.155721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Schachne JM, Durbin LL, Lacher CR, Sangha M, Mone A, Swaminath A. Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab071] [Reference Citation Analysis]
68 Song EM, Joo YH, Choe AR, Park Y, Tae CH, Hong JT, Moon CM, Kim SE, Jung HK, Shim KN, Cho KA, Jo I, Jung SA. Three-dimensional culture method enhances the therapeutic efficacies of tonsil-derived mesenchymal stem cells in murine chronic colitis model. Sci Rep 2021;11:19589. [PMID: 34599237 DOI: 10.1038/s41598-021-98711-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Zheng S, Zhuang T, Tang Y, Wu R, Xu T, Leng T, Wang Y, Lin Z, Ji M. Leonurine protects against ulcerative colitis by alleviating inflammation and modulating intestinal microflora in mouse models. Exp Ther Med 2021;22:1199. [PMID: 34584544 DOI: 10.3892/etm.2021.10633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Riansuwan W, Limsrivilai J. Current status of IBD and surgery of Crohn's disease in Thailand. Ann Gastroenterol Surg 2021;5:597-603. [PMID: 34585044 DOI: 10.1002/ags3.12470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
71 Yang L, Luo H, Tan D, Zhang S, Zhong Z, Wang S, Vong CT, Wang Y. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease. Phytomedicine 2021;92:153709. [PMID: 34560518 DOI: 10.1016/j.phymed.2021.153709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
72 Sun YX, Wang X, Liao X, Guo J, Hou WB, Wang X, Liu JP, Liu ZL. An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis. BMC Complement Med Ther 2021;21:228. [PMID: 34517855 DOI: 10.1186/s12906-021-03387-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Dash KR, Panda C, Das HS, Mishra D, Behera SK, Parida PK, Mohapatra D. Association of Vitamin D Level With Disease Severity and Quality of Life in Newly Diagnosed Patients of Ulcerative Colitis: A Cross-Sectional Analysis. Cureus 2021;13:e16481. [PMID: 34430097 DOI: 10.7759/cureus.16481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Jain M, Venkataraman J. Inflammatory bowel disease: An Indian perspective. Indian J Med Res 2021;153:421-30. [PMID: 34380788 DOI: 10.4103/ijmr.IJMR_936_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
75 Zou J, Liu C, Jiang S, Qian D, Duan J. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis. Infect Immun 2021;89:e0001421. [PMID: 33526559 DOI: 10.1128/IAI.00014-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
76 Moreno LO, Fernández-tomé S, Abalo R. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions. Biologics 2021;1:189-210. [DOI: 10.3390/biologics1020012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
77 Park J, Park S, Lee SA, Park SJ, Cheon JH. Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management. Korean J Intern Med 2021. [PMID: 34344146 DOI: 10.3904/kjim.2021.114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
78 Kim JM, Kang JG, Kim S, Cheon JH. Deep-learning system for real-time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis. J Gastroenterol Hepatol 2021;36:2141-8. [PMID: 33554375 DOI: 10.1111/jgh.15433] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
79 He XX, Li YH, Yan PG, Meng XC, Chen CY, Li KM, Li JN. Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis. World J Gastroenterol 2021; 27(28): 4722-4737 [PMID: 34366632 DOI: 10.3748/wjg.v27.i28.4722] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
80 Chen Y, Li H, Feng J, Suo S, Feng Q, Shen J. A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn's Disease. J Inflamm Res 2021;14:2731-40. [PMID: 34194236 DOI: 10.2147/JIR.S314912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
81 Rubalcava NS, Gadepalli SK. Inflammatory Bowel Disease in Children and Adolescents. Adv Pediatr 2021;68:121-42. [PMID: 34243849 DOI: 10.1016/j.yapd.2021.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
82 Liang L, Lin R, Xie Y, Lin H, Shao F, Rui W, Chen H. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer. Int J Biol Sci 2021;17:2548-60. [PMID: 34326693 DOI: 10.7150/ijbs.58671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Si Y, Shao L, Gao S, Wen H. Suppository treatment in ulcerative proctitis. Eur J Inflamm 2021;19:205873922110151. [DOI: 10.1177/20587392211015108] [Reference Citation Analysis]
84 Ferrante M, Feagan BG, Panés J, Baert F, Louis E, Dewit O, Kaser A, Duan WR, Pang Y, Lee WJ, Gustafson D, Liao X, Wallace K, Kalabic J, D'Haens GR. Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study. J Crohns Colitis 2021;15:2001-10. [PMID: 34077509 DOI: 10.1093/ecco-jcc/jjab093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
85 Agrawal M, Corn G, Shrestha S, Nielsen NM, Frisch M, Colombel JF, Jess T. Inflammatory bowel diseases among first-generation and second-generation immigrants in Denmark: a population-based cohort study. Gut 2021;70:1037-43. [PMID: 32895335 DOI: 10.1136/gutjnl-2020-321798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
86 Li BL, Zhao DY, Du PL, Wang XT, Yang Q, Cai YR. Luteolin alleviates ulcerative colitis through SHP-1/STAT3 pathway. Inflamm Res 2021;70:705-17. [PMID: 34014331 DOI: 10.1007/s00011-021-01468-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
87 Kim SB, Cheon JH, Park JJ, Kim ES, Jeon SW, Jung SA, Park DI, Lee CK, Im JP, Kim YS, Kim HS, Lee J, Eun CS, Lee JM, Jang BI, Seo GS. Risk Factors for Postoperative Recurrence in Korean Patients with Crohn's Disease. Gut Liver 2020;14:331-7. [PMID: 31550869 DOI: 10.5009/gnl19085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
88 Song DJ, Shen J, Chen MH, Liu ZJ, Cao Q, Hu PJ, Gao X, Qian JM, Wu KC, Lai LJ, Ran ZH. Association of Serum Immunoglobulins Levels With Specific Disease Phenotypes of Crohn's Disease: A Multicenter Analysis in China. Front Med (Lausanne) 2021;8:621337. [PMID: 33996846 DOI: 10.3389/fmed.2021.621337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Zhou G, Kong WS, Li ZC, Xie RF, Yu TY, Zhou X. Effects of Qing Chang Suppository Powder and its Ingredients on IL-17 Signal Pathway in HT-29 Cells and DSS-induced Mice. Phytomedicine 2021;87:153573. [PMID: 34052543 DOI: 10.1016/j.phymed.2021.153573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Wu G, Yang Y, Liu M, Wang Y, Guo Q. Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease. Front Pharmacol 2021;12:655865. [PMID: 33935772 DOI: 10.3389/fphar.2021.655865] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
91 Chen Y, Li H, Feng Q, Shen J. Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn's Disease Patients. Front Pharmacol 2021;12:654985. [PMID: 33986682 DOI: 10.3389/fphar.2021.654985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Bilal M, Nunes LV, Duarte MTS, Ferreira LFR, Soriano RN, Iqbal HMN. Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease. Mar Drugs 2021;19:196. [PMID: 33808253 DOI: 10.3390/md19040196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
93 Loftus EV. The increasing burden of inflammatory bowel disease. Med J Aust 2021;214:361-2. [PMID: 33774833 DOI: 10.5694/mja2.51001] [Reference Citation Analysis]
94 Gong SS, Fan YH, Lv B, Zhang MQ, Xu Y, Zhao J. Fatigue in patients with inflammatory bowel disease in Eastern China. World J Gastroenterol 2021; 27(11): 1076-1089 [PMID: 33776374 DOI: 10.3748/wjg.v27.i11.1076] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
95 Chen H, Vannuccini S, Capezzuoli T, Ceccaroni M, Mubiao L, Shuting H, Wu Y, Huang H, Petraglia F. Comorbidities and Quality of Life in Women Undergoing First Surgery for Endometriosis: Differences Between Chinese and Italian Population. Reprod Sci 2021;28:2359-66. [PMID: 33751460 DOI: 10.1007/s43032-021-00487-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
96 Ahmed M, Metwaly A, Haller D. Modeling microbe-host interaction in the pathogenesis of Crohn's disease. Int J Med Microbiol 2021;311:151489. [PMID: 33676240 DOI: 10.1016/j.ijmm.2021.151489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Zeng W, He D, Xing Y, Liu J, Su N, Zhang C, Wang Y, Xing X. Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review. Food Science and Human Wellness 2021;10:119-30. [DOI: 10.1016/j.fshw.2021.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
98 Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, Nie Y, Chen Y. Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Front Nutr 2021;8:615064. [PMID: 33718417 DOI: 10.3389/fnut.2021.615064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
99 Niriella MA, Liyanage IK, Kodisinghe SK, De Silva AP, Jayatissa AVGAM, Navarathne NMM, Peiris RK, Kalubovila UP, Kumarasena SR, Jayasekara RW, de Silva HJ. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study. BMC Gastroenterol 2021;21:71. [PMID: 33593289 DOI: 10.1186/s12876-021-01644-5] [Reference Citation Analysis]
100 Park J, Cheon JH. Incidence and Prevalence of Inflammatory Bowel Disease across Asia. Yonsei Med J 2021;62:99-108. [PMID: 33527789 DOI: 10.3349/ymj.2021.62.2.99] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
101 Gearry RB, McCombie AM, Vatn M, Rubin DT, Steinwurz F, Loftus EV, Kruis W, Tysk C, Colombel JF, Ng SC, Van Assche G, Bernstein CN. What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries. Inflamm Intest Dis 2021;6:78-86. [PMID: 34124179 DOI: 10.1159/000512310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Park SK, Wong Z, Park SH, Vu KV, Bang KB, Piyachaturawat P, Myint T, Hilmi I, Park DI. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study. Dig Liver Dis 2021;53:196-201. [PMID: 32736897 DOI: 10.1016/j.dld.2020.06.046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
103 Cui G, Li J, Liu H, Laugsand J, Liu Z. Differences in inflammatory bowel diseases between East and West: a Chinese perspective. J Public Health (Berl ) 2021;29:19-26. [DOI: 10.1007/s10389-019-01102-3] [Reference Citation Analysis]
104 Pudipeddi A, Liu J, Kariyawasam V, Borody TJ, Cowlishaw JL, McDonald C, Katelaris P, Chapman G, Corte C, Lemberg DA, Lee CH, Keshava A, Napoli J, Clancy R, Chan W, Paramsothy S, Leong R. High prevalence of Crohn disease and ulcerative colitis among older people in Sydney. Med J Aust 2021;214:365-70. [PMID: 33502004 DOI: 10.5694/mja2.50910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
105 Na S. Therapeutic Approach to Inflammatory Bowel Disease Using Human Microbial Modification. Korean J Gastroenterol 2021;77:1-3. [DOI: 10.4166/kjg.2021.012] [Reference Citation Analysis]
106 Heo CM, Kim TJ, Kim ER, Hong SN, Chang DK, Yang M, Kim S, Kim YH. Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study. Sci Rep 2021;11:2025. [PMID: 33479464 DOI: 10.1038/s41598-021-81657-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
107 Cao F, Cheng YS, Yu L, Xu YY, Wang Y. Bioinformatics Analysis of Differentially Expressed Genes and Protein-Protein Interaction Networks Associated with Functional Pathways in Ulcerative Colitis. Med Sci Monit 2021;27:e927917. [PMID: 33462173 DOI: 10.12659/MSM.927917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
108 Hong JT, Kim ER, Park SW, Kim JW, Hong SN, Chang DK, Kim YH, Cho JH. Long-term Prognosis of Localized Lymphoid Hyperplasia of the Rectum. Gut Liver 2021;15:77-84. [PMID: 32062874 DOI: 10.5009/gnl19288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
109 Jin HY, Lim JS, Lee Y, Choi Y, Oh SH, Kim KM, Yoo HW, Choi JH. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr 2021;21:35. [PMID: 33446154 DOI: 10.1186/s12887-021-02496-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
110 Rodríguez LM, Izmirlian G, Young PE. A deeper dive into disparities in IBD: Data from the ACS NSQIP. Am J Surg 2021;221:666-7. [PMID: 33551117 DOI: 10.1016/j.amjsurg.2021.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Yang Y, Cui X, Li J, Wang H, Li Y, Chen Y, Zhang H. Clinical evaluation of vitamin D status and its relationship with disease activity and changes of intestinal immune function in patients with Crohn's disease in the Chinese population. Scand J Gastroenterol 2021;56:20-9. [PMID: 33205696 DOI: 10.1080/00365521.2020.1844793] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
112 Banerjee S. Nanoparticle-Mediated Therapeutic Approach for Ulcerative Colitis Treatment. Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer 2021. [DOI: 10.4018/978-1-7998-3580-6.ch005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:56-66. [PMID: 33033392 DOI: 10.1038/s41575-020-00360-x] [Cited by in Crossref: 187] [Cited by in F6Publishing: 168] [Article Influence: 93.5] [Reference Citation Analysis]
114 Liu K, Jia B, Zhou L, Xing L, Wu L, Li Y, Lu J, Zhang L, Guan S. Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics and Lipidomics Identify Biomarkers for Efficacy Evaluation of Mesalazine in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model. J Proteome Res 2021;20:1371-81. [PMID: 33356298 DOI: 10.1021/acs.jproteome.0c00757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
115 Lin J, Li G, Xu C, Lu H, Zhang C, Pang Z, Liu Z. Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities. Mediators Inflamm 2020;2020:8812020. [PMID: 33488293 DOI: 10.1155/2020/8812020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
116 Liu H, Li T, Zhong S, Yu M, Huang W. Intestinal epithelial cells related lncRNA and mRNA expression profiles in dextran sulphate sodium-induced colitis. J Cell Mol Med 2021;25:1060-73. [PMID: 33300279 DOI: 10.1111/jcmm.16174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
117 Kaur G, Singh SK, Kumar R, Kumar B, Kumari Y, Gulati M, Pandey NK, Gowthamarajan K, Ghosh D, Clarisse A, Wadhwa S, Mehta M, Satija S, Dua K, Dureja H, Gupta S, Singh PK, Kapoor B, Chitranshi N, Kumar A, Porwal O. Development of modified apple polysaccharide capped silver nanoparticles loaded with mesalamine for effective treatment of ulcerative colitis. Journal of Drug Delivery Science and Technology 2020;60:101980. [DOI: 10.1016/j.jddst.2020.101980] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
118 Steinberg JM, Sarkis Y, Kallus SJ, Charabaty A. Biologic Therapy in Elderly Patients with IBD: Current Trends and Special Management Considerations. Curr Treat Options Gastro 2020;18:623-634. [DOI: 10.1007/s11938-020-00309-8] [Reference Citation Analysis]
119 Rajbhandari R, Blakemore S, Gupta N, Adler AJ, Noble CA, Mannan S, Nikolli K, Yih A, Joshi S, Bukhman G. Crohn’s disease in low and lower-middle income countries: A scoping review. World J Gastroenterol 2020; 26(43): 6891-6908 [PMID: 33268969 DOI: 10.3748/wjg.v26.i43.6891] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
120 Alkhatry M, Al-Rifai A, Annese V, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani R, Taha MS, Limdi JK. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World J Gastroenterol 2020; 26(43): 6710-6769 [PMID: 33268959 DOI: 10.3748/wjg.v26.i43.6710] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
121 Bodiwala V, Marshall T, Das KM, Brant SR, Seril DN. Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center. Inflamm Bowel Dis 2020;26:1869-77. [PMID: 32144933 DOI: 10.1093/ibd/izaa019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
122 Karmiris K. Racial Differences in Inflammatory Bowel Disease: A Race With Alternating Winners? Inflamm Bowel Dis 2020;26:1878-9. [PMID: 32144931 DOI: 10.1093/ibd/izaa022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Lv H, Jin M, Zhang H, Chen X, Wu M, Guo M, Zhou R, Wang Z, Yang H, Qian J. Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre. BMC Gastroenterol 2020;20:377. [PMID: 33183228 DOI: 10.1186/s12876-020-01527-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
124 Singh S, Bhatia R, Khare P, Sharma S, Rajarammohan S, Bishnoi M, Bhadada SK, Sharma SS, Kaur J, Kondepudi KK. Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice. Sci Rep 2020;10:18597. [PMID: 33122795 DOI: 10.1038/s41598-020-75702-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
125 Choi YI, Park SJ, Chung JW, Kim KO, Cho JH, Kim YJ, Lee KY, Kim KG, Park DK. Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study.J Clin Med. 2020;9:3427. [PMID: 33114505 DOI: 10.3390/jcm9113427] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
126 Wang SY, Zhao JM, Zhou CL, Zheng HD, Huang Y, Zhao M, Zhang ZY, Wu LY, Wu HG, Liu HR. Herbal cake-partitioned moxibustion inhibits colonic autophagy in Crohn’s disease via signaling involving distinct classes of phosphatidylinositol 3-kinases. World J Gastroenterol 2020; 26(39): 5997-6014 [PMID: 33132650 DOI: 10.3748/wjg.v26.i39.5997] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Vuyyuru SK, Sahu P, Kedia S, Kante B, Kumar P, Ranjan MK, Sharma R, Makharia G, Gupta SD, Sahni P, Ahuja V. Long-term outcomes in perianal fistulizing Crohn's disease in a resource-limited setting: A cohort analysis. Indian J Gastroenterol 2020;39:435-44. [PMID: 33040321 DOI: 10.1007/s12664-020-01054-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
128 Limsrivilai J, Aniwan S, Sudcharoen A, Chaisidhivej N, Prueksapanich P, Pausawasdi N, Charatcharoenwitthaya P, Pongprasobchai S, Manassatit S. Temporal trend of disease recognition, treatment paradigm, and clinical outcomes of Crohn disease in Thailand from 2000 through 2017: Is early use of thiopurines beneficial? Medicine (Baltimore) 2020;99:e22216. [PMID: 32957358 DOI: 10.1097/MD.0000000000022216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
129 Dober M, Mikocka-Walus A, Evans S, Beswick L, Emerson C, Olive L. Perspectives on an Acceptance and Commitment Therapy (ACT) based program for patients with inflammatory bowel disease and comorbid anxiety and/or depressive symptoms. Psychother Res 2021;31:668-81. [PMID: 32892715 DOI: 10.1080/10503307.2020.1813915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Zareef R, Younis N, Mahfouz R. Inflammatory bowel disease: A key role for microbiota? Meta Gene 2020;25:100713. [DOI: 10.1016/j.mgene.2020.100713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
131 Lautenschlager SA, Fournier N, Biedermann L, Pittet V, Schreiner P, Misselwitz B, Scharl M, Rogler G, Siebenhüner AR. The Influence of Breastfeeding, Cesarean Section, Pet Animals, and Urbanization on the Development of Inflammatory Bowel Disease: Data from the Swiss IBD Cohort Study. Inflamm Intest Dis 2020;5:170-9. [PMID: 33313069 DOI: 10.1159/000509058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
132 Dhoble P, Desai D, Abraham P. Is the rise in Crohn's disease in India accompanied by a fall in intestinal tuberculosis? A single-center experience. Indian J Tuberc 2021;68:210-4. [PMID: 33845954 DOI: 10.1016/j.ijtb.2020.08.010] [Reference Citation Analysis]
133 Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan GG, Lix LM. Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults. J Can Assoc Gastroenterol 2021;4:186-93. [PMID: 34337319 DOI: 10.1093/jcag/gwaa028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
134 Aniwan S, Limsrivilai J, Pongprasobchai S, Pausawasdi N, Prueksapanich P, Kongtub N, Rerknimitr R. Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through 2018. Intest Res 2021;19:186-93. [PMID: 32806871 DOI: 10.5217/ir.2020.00028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
135 Arai K, Kunisaki R, Kakuta F, Hagiwara SI, Murakoshi T, Yanagi T, Shimizu T, Kato S, Ishige T, Aomatsu T, Inoue M, Saito T, Iwama I, Kawashima H, Kumagai H, Tajiri H, Iwata N, Mochizuki T, Noguchi A, Kashiwabara T, Shimizu H, Suzuki Y, Hirano Y, Fujiwara T. Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry. Intest Res 2020;18:412-20. [PMID: 32806870 DOI: 10.5217/ir.2019.00130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
136 Phisalprapa P, Kositamongkol C, Limsrivilai J, Aniwan S, Charatcharoenwitthaya P, Pisespongsa P, Kitiyakara T, Treepongkaruna S, Chaiyakunapruk N. Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn's disease using real world evidence in Thailand. J Med Econ 2020;23:1302-10. [PMID: 32729347 DOI: 10.1080/13696998.2020.1803889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
137 Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol 2020; 26(28): 3998-4017 [PMID: 32821067 DOI: 10.3748/wjg.v26.i28.3998] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
138 Zhao D, Dai W, Tao H, Zhuang W, Qu M, Chang YN. Polysaccharide isolated from Auricularia auricular-judae (Bull.) prevents dextran sulfate sodium-induced colitis in mice through modulating the composition of the gut microbiota. J Food Sci 2020;85:2943-51. [PMID: 32702186 DOI: 10.1111/1750-3841.15319] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
139 Malesza IJ, Malesza M, Krela-Kaźmierczak I, Zielińska A, Souto EB, Dobrowolska A, Eder P. Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults. Int J Mol Sci 2020;21:E5223. [PMID: 32718006 DOI: 10.3390/ijms21155223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
140 Yan X, Qiao Y, Tong J, Mao R, Liang J, Lv C, Chen Y, Wang Y, Shen J; Young Investigators for the study of Inflammatory Bowel Diseases (YIIBD). Assessment of patient-centered outcomes (PROs) in inflammatory bowel disease (IBD): a multicenter survey preceding a cross-disciplinary (functional) consensus. Health Qual Life Outcomes 2020;18:241. [PMID: 32690091 DOI: 10.1186/s12955-020-01489-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
141 Hu W, Hu S, Zhu Y, Chen H, Chen Y. Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients. Patient Prefer Adherence 2020;14:1083-92. [PMID: 32669838 DOI: 10.2147/PPA.S250935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
142 Chen B, Gao X, Zhong J, Ren J, Zhu X, Liu Z, Wu K, Kalabic J, Yu Z, Huang B, Kwatra N, Doan T, Robinson AM, Chen MH. Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial. Therap Adv Gastroenterol 2020;13:1756284820938960. [PMID: 32733600 DOI: 10.1177/1756284820938960] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
143 Snell A, Segal J, Limdi J, Banerjee R. Inflammatory bowel disease in India: challenges and opportunities. Frontline Gastroenterol 2021;12:390-6. [DOI: 10.1136/flgastro-2020-101500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
144 Sood A, Kaur K, Mahajan R, Midha V, Singh A, Sharma S, Puri AS, Goswami B, Desai D, Pai CG, Peddi K, Philip M, Kochhar R, Nijhawan S, Bhatia S, Rao NS. Colitis and Crohn's Foundation (India): a first nationwide inflammatory bowel disease registry. Intest Res 2021;19:206-16. [PMID: 32646197 DOI: 10.5217/ir.2019.09169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
145 Lin Y, Koumba MH, Qu S, Wang D, Lin L. Blocking NFATc3 ameliorates azoxymethane/dextran sulfate sodium induced colitis-associated colorectal cancer in mice via the inhibition of inflammatory responses and epithelial-mesenchymal transition. Cell Signal 2020;74:109707. [PMID: 32653643 DOI: 10.1016/j.cellsig.2020.109707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
146 Rojas Rodríguez CA, Sánchez Londoño S, Rojas N, Sepúlveda Copete M, García Abadía JA, Jiménez Rivera DF, Maldonado Gutiérrez C, Tobón Guevara A. Descripción clínico-epidemiológica de pacientes con enfermedad inflamatoria intestinal en una clínica de cuarto nivel en Cali. Rev Colomb Gastroenterol 2020;35:166-173. [DOI: 10.22516/25007440.409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
147 Zhao Y, Xu M, Chen L, Liu Z, Sun X. Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn's disease in patients with positive results. Therap Adv Gastroenterol 2020;13:1756284820922003. [PMID: 32523624 DOI: 10.1177/1756284820922003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
148 Zhang T, Jiang J, Liu J, Xu L, Duan S, Sun L, Zhao W, Qian F. MK2 Is Required for Neutrophil-Derived ROS Production and Inflammatory Bowel Disease. Front Med (Lausanne) 2020;7:207. [PMID: 32596245 DOI: 10.3389/fmed.2020.00207] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
149 Demir A, Kahraman R, Candan G, Ergen A. The role of FAS gene variants in inflammatory bowel disease. Turk J Gastroenterol 2020;31:356-61. [PMID: 32519954 DOI: 10.5152/tjg.2020.19436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Mak JWY, Ng SC. Epidemiology of fibrostenosing inflammatory bowel disease. J Dig Dis 2020;21:332-5. [PMID: 32105396 DOI: 10.1111/1751-2980.12853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
151 Chuah KH, Raja Ali RA, Hilmi IN. Decreasing major surgical rates for Crohn's disease in an emerging economy over two decades: Is it due to biologic therapy? Indian J Gastroenterol 2020;39:261-7. [PMID: 32613522 DOI: 10.1007/s12664-020-01044-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Xie Y, Zhou L, Yao X, Li Y. Protective Effects of Clostridium Butyricum in a Murine Model of Dextran Sodium Sulfate-Induced Colitis That Involve Inhibition of the TLR2 Signaling Pathway and T Helper 17 Cells. Am J Med Sci 2020;360:176-91. [PMID: 32553747 DOI: 10.1016/j.amjms.2020.05.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
153 Zou J, Shen Y, Chen M, Zhang Z, Xiao S, Liu C, Wan Y, Yang L, Jiang S, Shang E, Qian D, Duan J. Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites. Appl Microbiol Biotechnol. 2020;104:5999-6012. [PMID: 32418127 DOI: 10.1007/s00253-020-10665-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
154 Chande N, Costello SP, Limketkai BN, Parker CE, Nguyen TM, Macdonald JK, Feagan BG. Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews. Inflamm Bowel Dis 2020;26:843-51. [PMID: 31560744 DOI: 10.1093/ibd/izz223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
155 Rampal R, Kedia S, Wari MN, Madhu D, Singh AK, Tiwari V, Mouli VP, Mohta S, Makharia G, Ahuja V. Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease. Intest Res 2021;19:232-8. [PMID: 32375209 DOI: 10.5217/ir.2019.09181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
156 Yeshi K, Ruscher R, Hunter L, Daly NL, Loukas A, Wangchuk P. Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. J Clin Med 2020;9:E1273. [PMID: 32354192 DOI: 10.3390/jcm9051273] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 15.3] [Reference Citation Analysis]
157 Kayama H, Tani H, Kitada S, Opasawatchai A, Okumura R, Motooka D, Nakamura S, Takeda K. BATF2 prevents T-cell-mediated intestinal inflammation through regulation of the IL-23/IL-17 pathway. Int Immunol 2019;31:371-83. [PMID: 30753547 DOI: 10.1093/intimm/dxz014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
158 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 162] [Cited by in F6Publishing: 172] [Article Influence: 54.0] [Reference Citation Analysis]
159 Yanai S, Toya Y, Nakamura S, Matsumoto T. Patients’ Preference of Topical Therapy for Ulcerative Colitis in Japan: A Web-based 3T Survey. Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otaa030] [Reference Citation Analysis]
160 Baranovsky AY, Kondrashina EA, Shchukina OB, Raikhelson KL, Palgova LK, Marchenko NV, Prashnova MK, Pazenko EV, Kovyazina VP, Segal AM. Clinical Features of Inflammatory Bowel Disease (Ulcerative Colitis and Crohn’s Disease) in Geriatric Practice in St. Petersburg. Adv Gerontol 2020;10:187-192. [DOI: 10.1134/s2079057020020034] [Reference Citation Analysis]
161 Ma S, Yeom J, Lim YH. Dairy Propionibacterium freudenreichii ameliorates acute colitis by stimulating MUC2 expression in intestinal goblet cell in a DSS-induced colitis rat model. Sci Rep 2020;10:5523. [PMID: 32218552 DOI: 10.1038/s41598-020-62497-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
162 Peppas S, Piovani D, Peyrin-Biroulet L, Danese S, Bonovas S. Statins and inflammatory bowel disease: Where do we stand? Eur J Intern Med 2020;75:10-4. [PMID: 32151491 DOI: 10.1016/j.ejim.2020.02.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
163 Takenaka K, Kitazume Y, Fujii T, Tsuchiya K, Watanabe M, Ohtsuka K. Objective evaluation for treat to target in Crohn's disease. J Gastroenterol 2020;55:579-87. [PMID: 32130521 DOI: 10.1007/s00535-020-01678-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
164 Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol 2020;35:380-9. [PMID: 31596960 DOI: 10.1111/jgh.14872] [Cited by in Crossref: 158] [Cited by in F6Publishing: 148] [Article Influence: 52.7] [Reference Citation Analysis]
165 Komaki S, Haque A, Miyazaki H, Matsumoto T, Nakamura S. Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice. J Infect Chemother 2020;26:549-53. [PMID: 32122783 DOI: 10.1016/j.jiac.2020.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
166 Lian Q, Yan S, Yin Q, Yan C, Zheng W, Gu W, Zhao X, Fan W, Li X, Ma L, Ling Z, Zhang Y, Liu J, Li J, Sun B. TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity. Cell Mol Immunol 2021;18:350-62. [PMID: 32094504 DOI: 10.1038/s41423-020-0366-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
167 Zhou L, Liu D, Xie Y, Yao X, Li Y. Bifidobacterium infantis Induces Protective Colonic PD-L1 and Foxp3 Regulatory T Cells in an Acute Murine Experimental Model of Inflammatory Bowel Disease. Gut Liver 2019;13:430-9. [PMID: 30600673 DOI: 10.5009/gnl18316] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
168 Moon JM, Kang EA, Han K, Hong SW, Soh H, Park S, Lee J, Lee HJ, Im JP, Kim JS. Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study. World J Gastroenterol 2020; 26(4): 404-415 [PMID: 32063689 DOI: 10.3748/wjg.v26.i4.404] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
169 Bhatia R, Yeoh SW, Vaz K, Studd C, Wilson J, Bell S, Otahal P, Venn A. Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania, Australia. Intern Med J 2019;49:622-30. [PMID: 30230160 DOI: 10.1111/imj.14111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
170 Sharifi L, Moshiri M, Dallal MMS, Asgardoon MH, Nourizadeh M, Bokaie S, Mirshafiey A. The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line. Recent Pat Inflamm Allergy Drug Discov 2019;13:57-65. [PMID: 30539708 DOI: 10.2174/1872213X13666181211160238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
171 Gu P, Feagins LA. Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD. Inflamm Bowel Dis 2020;26:181-91. [PMID: 31670372 DOI: 10.1093/ibd/izz268] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
172 Genin M, Fumery M, Occelli F, Savoye G, Pariente B, Dauchet L, Giovannelli J, Vignal C, Body-Malapel M, Sarter H, Gower-Rousseau C, Ficheur G. Fine-scale geographical distribution and ecological risk factors for Crohn's disease in France (2007-2014). Aliment Pharmacol Ther 2020;51:139-48. [PMID: 31588597 DOI: 10.1111/apt.15512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
173 Zhao D, Wu N, Wang L, Pang X, Liu X, Zhang X. Role of microRNA-449a in the progress of inflammatory bowel disease in children. Biotechnology & Biotechnological Equipment 2020;34:144-53. [DOI: 10.1080/13102818.2020.1724828] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
174 Timmer A. Epidemiologie der chronisch-entzündlichen Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_2] [Reference Citation Analysis]
175 Parigi TL, Roda G, Argollo M, Gilardi D, Danese S, Peyrin-biroulet L. Is there a role for therapeutic sphingolipids in inflammatory bowel disease? Expert Review of Gastroenterology & Hepatology 2020;14:47-54. [DOI: 10.1080/17474124.2020.1709446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
176 Huang JG, Aw MM. Pediatric Inflammatory Bowel Disease in Asia: Epidemiology and natural history. Pediatr Neonatol 2020;61:263-71. [PMID: 32005607 DOI: 10.1016/j.pedneo.2019.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
177 Lv H, Qiao B, Fang L, Yang L, Wang Q, Wu S, Ren P, Li L. Neonatal Crohn's disease with Oral ulcer as the first symptom caused by a compound heterozygote mutation in IL-10RA: a case report. Hereditas 2019;156:38. [PMID: 31889944 DOI: 10.1186/s41065-019-0114-8] [Reference Citation Analysis]
178 Selvaratnam S, Gullino S, Shim L, Lee E, Lee A, Paramsothy S, Leong RW. Epidemiology of inflammatory bowel disease in South America: A systematic review. World J Gastroenterol 2019; 25(47): 6866-6875 [PMID: 31885427 DOI: 10.3748/wjg.v25.i47.6866] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
179 Lin WC, Weng MT, Tung CC, Chang YT, Leong YL, Wang YT, Wang HY, Wong JM, Wei SC. Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study. J Transl Med 2019;17:414. [PMID: 31831015 DOI: 10.1186/s12967-019-02164-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
180 Allen PB, Bonovas S, Danese S, Peyrin-Biroulet L. Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective. Expert Opin Biol Ther 2020;20:151-61. [PMID: 31815548 DOI: 10.1080/14712598.2020.1702020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Chen YH, Xiang Y. Efficacy of resveratrol for the treatment in patients with ulcerative colitis: Study Protocol. Medicine (Baltimore) 2019;98:e17938. [PMID: 31725648 DOI: 10.1097/MD.0000000000017938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
182 Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological Mechanisms Underpinning Faecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Clin Exp Immunol. 2019;199:24-38. [PMID: 31777058 DOI: 10.1111/cei.13397] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
183 Du J, Du H, Chen H, Shen L, Zhang B, Xu W, Zhang Z, Chen C. Characteristics and prognosis of isolated small-bowel Crohn’s disease. Int J Colorectal Dis 2020;35:69-75. [DOI: 10.1007/s00384-019-03432-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
184 Safarpour AR, Mehrabi M, Keshtkar A, Edjtehadi F, Bagheri Lankarani K. Systematic review and meta-analysis of the incidence and prevalence and 30-year trend of inflammatory bowel diseases in Asia: a study protocol. BMJ Open 2019;9:e031854. [PMID: 31748306 DOI: 10.1136/bmjopen-2019-031854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
185 Chen Y, Wang Y, Shen J. Role of environmental factors in the pathogenesis of Crohn’s disease: a critical review. Int J Colorectal Dis 2019;34:2023-34. [DOI: 10.1007/s00384-019-03441-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
186 Lee J, Im JP, Han K, Park S, Soh H, Choi K, Kim J, Chun J, Kim JS. Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study. World J Gastroenterol 2019; 25(42): 6354-6364 [PMID: 31754295 DOI: 10.3748/wjg.v25.i42.6354] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
187 Ma Q, Ouyang Y, Meng F, Noolvi MN, Avvaru SP, More UA, Aminabhavi TM, Du M, Liu H, Zhuang Y, Pang M, Cai T, Cai Y. A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of Ulcerative colitis. Journal of Ethnopharmacology 2019;244:112105. [DOI: 10.1016/j.jep.2019.112105] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
188 Jeon M, Song K, Koo J, Kim S. Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease. Ann Coloproctol. 2019;35:249-253. [PMID: 31726000 DOI: 10.3393/ac.2018.11.23.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
189 Park SH, Kim YJ, Rhee KH, Kim YH, Hong SN, Kim KH, Seo SI, Cha JM, Park SY, Jeong SK, Lee JH, Park H, Kim JS, Im JP, Yoon H, Kim SH, Jang J, Kim JH, Suh SO, Kim YK, Ye BD, Yang SK; Songpa-Kangdong Inflammatory Bowel Disease [SK-IBD] Study Group. A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015. J Crohns Colitis 2019;13:1410-7. [PMID: 30989166 DOI: 10.1093/ecco-jcc/jjz081] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 22.8] [Reference Citation Analysis]
190 Misra R, Limdi J, Cooney R, Sakuma S, Brookes M, Fogden E, Pattni S, Sharma N, Iqbal T, Munkholm P, Burisch J, Arebi N. Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study. World J Gastroenterol 2019; 25(40): 6145-6157 [PMID: 31686769 DOI: 10.3748/wjg.v25.i40.6145] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
191 Stevens JP, Ballengee CR, Chandradevan R, Thompson AB, Schoen BT, Kugathasan S, Sauer CG. Performance of Interferon-Gamma Release Assays for Tuberculosis Screening in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:e111-6. [PMID: 31261245 DOI: 10.1097/MPG.0000000000002428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
192 Ding S, Ma Y, Liu G, Yan W, Jiang H, Fang J. Lactobacillus brevis Alleviates DSS-Induced Colitis by Reprograming Intestinal Microbiota and Influencing Serum Metabolome in Murine Model. Front Physiol 2019;10:1152. [PMID: 31620010 DOI: 10.3389/fphys.2019.01152] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
193 Lin KD, Chiu GF, Waljee AK, Owyang SY, El-Zaatari M, Bishu S, Grasberger H, Zhang M, Wu DC, Kao JY. Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2019;17:1991-9. [PMID: 30580094 DOI: 10.1016/j.cgh.2018.12.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
194 Burisch J, Jess T. Does Eradication of Helicobacter Pylori Cause Inflammatory Bowel Disease? Clin Gastroenterol Hepatol 2019;17:1940-1. [PMID: 30768965 DOI: 10.1016/j.cgh.2019.02.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
195 Shi X, Yang W, Wang N, Zhu J. Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients. Medicine (Baltimore) 2019;98:e16622. [PMID: 31415355 DOI: 10.1097/MD.0000000000016622] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
196 Sun F, Liang W, Tang K, Hong M, Qian J. Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer. PeerJ 2019;7:e7451. [PMID: 31523496 DOI: 10.7717/peerj.7451] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
197 Chen M, Yuan C, Xu T. An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2020;44:302-9. [PMID: 31447293 DOI: 10.1016/j.clinre.2019.07.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
198 Li Y, Chen B, Gao X, Hu N, Huang M, Ran Z, Liu Z, Zhong J, Zou D, Wu X, Ren J, Sheng J, Zheng P, Wang H, Chen M, Chen J, Xi P, Lu J, Handel M, Liu Y, Fan H, Qian J. Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry. BMC Gastroenterol. 2019;19:145. [PMID: 31420025 DOI: 10.1186/s12876-019-1057-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
199 Qiao Y, Ran Z. Potential influential factors on incidence and prevalence of inflammatory bowel disease in mainland China. JGH Open 2020;4:11-5. [PMID: 32055691 DOI: 10.1002/jgh3.12238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
200 Liu X, Wang C. Melatonin alleviates circadian rhythm disruption exacerbating DSS-induced colitis by inhibiting the distribution of HMGB1 in intestinal tissues. International Immunopharmacology 2019;73:108-17. [DOI: 10.1016/j.intimp.2019.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
201 Mak JW, Sung JJ. The Use of Biologics and Biosimilar in Asian patients with IBD: Are we ready? J Gastroenterol Hepatol 2019;34:1269-70. [PMID: 31456235 DOI: 10.1111/jgh.14817] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
202 Chen YY, Mao LZ, Liu HH, Sun SX. Mechanism of gut butyric acid producing bacteria for prevention and treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2019; 27(14): 907-912 [DOI: 10.11569/wcjd.v27.i14.907] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
203 Woo MH, Cho YH, Sohn MJ, Lee EJ, Kim JW, Moon JS, Ko JS, Kim HY. Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease. Pediatr Gastroenterol Hepatol Nutr 2019;22:358-68. [PMID: 31338311 DOI: 10.5223/pghn.2019.22.4.358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
204 Chen D, Ma J, Ben Q, Lu L, Wan X. Prior Appendectomy and the Onset and Course of Crohn's Disease in Chinese Patients. Gastroenterol Res Pract 2019;2019:8463926. [PMID: 31396275 DOI: 10.1155/2019/8463926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
205 Murakami Y, Nishiwaki Y, Oba MS, Asakura K, Ohfuji S, Fukushima W, Suzuki Y, Nakamura Y. Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol 2019;54:1070-7. [PMID: 31309327 DOI: 10.1007/s00535-019-01603-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 13.0] [Reference Citation Analysis]
206 Wright EK, Ding NS, Niewiadomski O. Management of inflammatory bowel disease. Med J Aust 2018;209:318-23. [PMID: 30257634 DOI: 10.5694/mja17.01001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
207 Schreiner P, Neurath MF, Ng SC, El-Omar EM, Sharara AI, Kobayashi T, Hisamatsu T, Hibi T, Rogler G. Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflamm Intest Dis 2019;4:79-96. [PMID: 31559260 DOI: 10.1159/000500721] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
208 Zhang YL, Cai LT, Qi JY, Lin YZ, Dai YC, Jiao N, Chen YL, Zheng L, Wang BB, Zhu LX, Tang ZP, Zhu RX. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis. World J Gastroenterol 2019; 25(25): 3242-3255 [PMID: 31333315 DOI: 10.3748/wjg.v25.i25.3242] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
209 Papada E, Kaliora AC. Antioxidant and Anti-Inflammatory Properties of Mastiha: A Review of Preclinical and Clinical Studies. Antioxidants (Basel) 2019;8:E208. [PMID: 31284520 DOI: 10.3390/antiox8070208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
210 Tepler A, Narula N, Peek RM Jr, Patel A, Edelson C, Colombel JF, Shah SC. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:121-31. [PMID: 31165513 DOI: 10.1111/apt.15306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
211 Ha JE, Jang EJ, Im SG, Sohn HS. Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014). Korean J Clin Pharm 2019;29:79-88. [DOI: 10.24304/kjcp.2019.29.2.79] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
212 Castro F, de Souza HSP. Dietary Composition and Effects in Inflammatory Bowel Disease. Nutrients 2019;11:E1398. [PMID: 31234325 DOI: 10.3390/nu11061398] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
213 Mokhtar NM, Nawawi KNM, Verasingam J, Zhiqin W, Sagap I, Azman ZAM, Mazlan L, Hamid HA, Yaacob NY, Rose IM, Den ELN, Wan MS, Raja Ali RA. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. BMC Public Health 2019;19:550. [PMID: 31196184 DOI: 10.1186/s12889-019-6858-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
214 Lee HS, Cleynen I. Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making? Cells. 2019;8. [PMID: 31167397 DOI: 10.3390/cells8060535] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
215 Kwak MS, Cha JM, Lee HH, Choi YS, Seo SI, Ko KJ, Park DI, Kim SH, Kim TJ. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study. J Gastroenterol Hepatol 2019;34:1018-26. [PMID: 30447025 DOI: 10.1111/jgh.14542] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
216 Yang Y, Xiang L, He J. Beverage intake and risk of Crohn disease: A meta-analysis of 16 epidemiological studies. Medicine (Baltimore) 2019;98:e15795. [PMID: 31124976 DOI: 10.1097/MD.0000000000015795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
217 Azzman N. Crohn's Disease: Potential Drugs for Modulation of Autophagy. Medicina (Kaunas) 2019;55:E224. [PMID: 31146413 DOI: 10.3390/medicina55060224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
218 Sabino J, Verstockt B, Vermeire S, Ferrante M. New biologics and small molecules in inflammatory bowel disease: an update. Therap Adv Gastroenterol 2019;12:1756284819853208. [PMID: 31205488 DOI: 10.1177/1756284819853208] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 14.8] [Reference Citation Analysis]
219 Kelleher M, Singh R, O'Driscoll CM, Melgar S. Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease. Cytokine Growth Factor Rev 2019;47:21-31. [PMID: 31133507 DOI: 10.1016/j.cytogfr.2019.05.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
220 Jang EJ, Ha JE, Im SG, Kim MG, Sohn HS. A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease. Clin Drug Investig 2019;39:625-30. [DOI: 10.1007/s40261-019-00784-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
221 Permpoon V, Pongpirul K, Anuras S. Five-year clinical outcomes of Crohn's disease: a report of 287 multiethnic cases from an International Hospital in Thailand. Clin Exp Gastroenterol 2019;12:203-8. [PMID: 31190947 DOI: 10.2147/CEG.S197255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
222 Cheng C, Hua J, Tan J, Qian W, Zhang L, Hou X. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis. Exp Ther Med 2019;18:278-88. [PMID: 31258663 DOI: 10.3892/etm.2019.7541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
223 Liu Y, Liu X. Research progress of P2X7 receptor in inflammatory bowel disease. Scand J Gastroenterol 2019;54:521-7. [PMID: 31056977 DOI: 10.1080/00365521.2019.1609077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
224 Zheng JD, He Y, Yu HY, Liu YL, Ge YX, Li XT, Li X, Wang Y, Guo MR, Qu YL, Qin XF, Jiang MS, Wang XH. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation. World J Gastroenterol 2019; 25(15): 1865-1878 [PMID: 31057300 DOI: 10.3748/wjg.v25.i15.1865] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
225 Teruel AH, Pérez-esteve É, González-álvarez I, González-álvarez M, Costero AM, Ferri D, Gaviña P, Merino V, Martínez-máñez R, Sancenón F. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease. Mol Pharmaceutics 2019;16:2418-29. [DOI: 10.1021/acs.molpharmaceut.9b00041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
226 Bao C, Liu P, Liu H, Jin X, Shi Y, Wu L, Zeng X, Zhang J, Wang D, Calhoun VD, Tian J, Wu H. Difference in regional neural fluctuations and functional connectivity in Crohn's disease: a resting-state functional MRI study. Brain Imaging Behav 2018;12:1795-803. [PMID: 29464530 DOI: 10.1007/s11682-018-9850-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
227 Shah SC, Khalili H, Chen CY, Ahn HS, Ng SC, Burisch J, Colombel JF. Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region. Aliment Pharmacol Ther 2019;49:904-11. [PMID: 30773656 DOI: 10.1111/apt.15178] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
228 Kim JW, Lee CK, Lee JK, Jeong SJ, Oh SJ, Moon JR, Kim HS, Kim HJ. Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006-2015). Scand J Gastroenterol 2019;54:419-26. [PMID: 30905222 DOI: 10.1080/00365521.2019.1591498] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
229 Lin YS, Cheng SW, Wang YH, Chen KH, Fang CJ, Chen C. Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn's disease. Aliment Pharmacol Ther 2019;49:966-77. [PMID: 30864199 DOI: 10.1111/apt.15184] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
230 Dalzell AM, Ba’ath ME. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Paediatrics and International Child Health 2019;39:48-58. [DOI: 10.1080/20469047.2019.1575056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
231 Lee J, Jee SR, Kim HW, Baek DH, Song GA, Moon W, Park SJ, Kim HJ, Lee JH, Park JH, Kim TO; Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS). Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis. PLoS One 2019;14:e0214129. [PMID: 30901362 DOI: 10.1371/journal.pone.0214129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
232 Oberc AM, Fiebig-Comyn AA, Tsai CN, Elhenawy W, Coombes BK. Antibiotics Potentiate Adherent-Invasive E. coli Infection and Expansion. Inflamm Bowel Dis 2019;25:711-21. [PMID: 30496418 DOI: 10.1093/ibd/izy361] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
233 Lee SR, Hwang HJ, Yoon JG, Bae EY, Goo KS, Cho SJ, Cho JA. Anti-inflammatory effect of Lycium barbarum on polarized human intestinal epithelial cells. Nutr Res Pract 2019;13:95-104. [PMID: 30984353 DOI: 10.4162/nrp.2019.13.2.95] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
234 He Y, Zhu Z, Chen Y, Chen F, Wang Y, Ouyang C, Yang H, Huang M, Zhuang X, Mao R, Ben-Horin S, Wu X, Ouyang Q, Qian J, Lu N, Hu P, Chen M. Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study. Am J Gastroenterol 2019;114:490-9. [PMID: 30741735 DOI: 10.14309/ajg.0000000000000064] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
235 Xie J, Liu Y, Chen B, Zhang G, Ou S, Luo J, Peng X. Ganoderma lucidum polysaccharide improves rat DSS-induced colitis by altering cecal microbiota and gene expression of colonic epithelial cells. Food Nutr Res 2019;63. [PMID: 30814921 DOI: 10.29219/fnr.v63.1559] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
236 Zhao YE, Zhu XQ. Continuous care education for patients with inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2019; 27(3): 197-202 [DOI: 10.11569/wcjd.v27.i3.197] [Reference Citation Analysis]
237 Aniwan S, Harmsen WS, Tremaine WJ, Loftus EV Jr. Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010. Therap Adv Gastroenterol 2019;12:1756284819827692. [PMID: 30792818 DOI: 10.1177/1756284819827692] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
238 Zang J, Ma S, Wang C, Guo G, Zhou L, Tian X, Lv M, Zhang J, Han B. Screening for active constituents in Turkish galls against ulcerative colitis by mass spectrometry guided preparative chromatography strategy: in silico, in vitro and in vivo study. Food Funct 2018;9:5124-38. [PMID: 30256363 DOI: 10.1039/c8fo01439f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
239 Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T. Gastrointestinal Tract Disorders in Older Age. Can J Gastroenterol Hepatol 2019;2019:6757524. [PMID: 30792972 DOI: 10.1155/2019/6757524] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 20.5] [Reference Citation Analysis]
240 Moon JS. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019;22:50-56. [PMID: 30671373 DOI: 10.5223/pghn.2019.22.1.50] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
241 Moon JS. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intest Res 2019;17:17-23. [PMID: 30625263 DOI: 10.5217/ir.2018.00139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
242 Savarino E, Bertani L, Ceccarelli L, Bodini G, Zingone F, Buda A, Facchin S, Lorenzon G, Marchi S, Marabotto E, De Bortoli N, Savarino V, Costa F, Blandizzi C. Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications. Expert Opin Biol Ther 2019;19:79-88. [PMID: 30574820 DOI: 10.1080/14712598.2019.1561852] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
243 Everhov ÅH, Sachs MC, Malmborg P, Nordenvall C, Myrelid P, Khalili H, Elmberg M, Ekbom A, Askling J, Jakobsson G, Halfvarson J, Ludvigsson JF, Olén O. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients. Scand J Gastroenterol 2019;54:55-63. [PMID: 30700170 DOI: 10.1080/00365521.2018.1564361] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
244 Kurti Z, Vegh Z, Gonczi L, Lakatos PL. Clinical Risk Factors: Lessons from Epidemiology. Biomarkers in Inflammatory Bowel Diseases 2019. [DOI: 10.1007/978-3-030-11446-6_2] [Reference Citation Analysis]
245 Zhang L, Wu T. Inflammatory Bowel Disease. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases 2019. [DOI: 10.1007/978-3-030-15573-5_15] [Reference Citation Analysis]
246 Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS, Tantry BV, Thapa BR, Goswami B, Behera BN, Ye BD, Bansal D, Desai D, Pai G, Yattoo GN, Makharia G, Wijewantha HS, Venkataraman J, Shenoy KT, Dwivedi M, Sahu MK, Bajaj M, Abdullah M, Singh N, Singh N, Abraham P, Khosla R, Tandon R, Misra SP, Nijhawan S, Sinha SK, Bopana S, Krishnaswamy S, Joshi S, Singh SP, Bhatia S, Gupta S, Bhatia S, Ghoshal UC. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol 2019;38:220-46. [PMID: 31352652 DOI: 10.1007/s12664-019-00976-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
247 Ng SC, Kaplan GG, Tang W, Banerjee R, Adigopula B, Underwood FE, Tanyingoh D, Wei SC, Lin WC, Lin HH, Li J, Bell S, Niewiadomski O, Kamm MA, Zeng Z, Chen M, Hu P, Ong D, Ooi CJ, Ling KL, Miao Y, Miao J, Janaka de Silva H, Niriella M, Aniwan S, Limsrivilai J, Pisespongsa P, Wu K, Yang H, Ng KK, Yu HH, Wang Y, Ouyang Q, Abdullah M, Simadibrata M, Gunawan J, Hilmi I, Lee Goh K, Cao Q, Sheng H, Ong-Go A, Chong VH, Ching JYL, Wu JCY, Chan FKL, Sung JJY. Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific. Am J Gastroenterol 2019;114:107-15. [PMID: 30177785 DOI: 10.1038/s41395-018-0233-2] [Cited by in Crossref: 109] [Cited by in F6Publishing: 109] [Article Influence: 27.3] [Reference Citation Analysis]
248 Na S. Asian Physician's Perspectives on Biosimilars in Inflammatory Bowel Disease: Are We Ready to Use? Korean J Gastroenterol 2019;74:301. [DOI: 10.4166/kjg.2019.74.6.301] [Reference Citation Analysis]
249 Zavos C. Stem Cells in Inflammatory Bowel Disease: From Pathogenesis to Clinical Practice. Stem Cell Biology and Regenerative Medicine 2019. [DOI: 10.1007/978-3-030-11965-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
250 Wang J, Chien W, Yang C, Chung C, Chen S, Liao W, Tsai Y. Association between aortic aneurysm and ulcerative colitis: A nationwide taiwanese retrospective cohort study. J Med Sci 2019;39:74. [DOI: 10.4103/jmedsci.jmedsci_99_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
251 Chan JSH, Chao ACW, Cheung VCH, Wong SSK, Tang W, Wu JCY, Chan HLY, Chan FKL, Sung JJY, Ng SC. Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014. J Gastroenterol Hepatol 2019;34:124-31. [PMID: 29995979 DOI: 10.1111/jgh.14377] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
252 Zhou YQ, Xu RY, Wan YP. The role of dietary factors in inflammatory bowel diseases: New perspectives. J Dig Dis 2019;20:11-7. [PMID: 30444028 DOI: 10.1111/1751-2980.12686] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
253 Kikut J, Konecka N, Ziętek M, Szczuko M. Inflammatory Bowel Disease Etiology: Current Knowledge. Pteridines 2018;29:206-14. [DOI: 10.1515/pteridines-2018-0020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
254 Reddavide R, Rotolo O, Caruso MG, Stasi E, Notarnicola M, Miraglia C, Nouvenne A, Meschi T, De' Angelis GL, Di Mario F, Leandro G. The role of diet in the prevention and treatment of Inflammatory Bowel Diseases. Acta Biomed 2018;89:60-75. [PMID: 30561397 DOI: 10.23750/abm.v89i9-S.7952] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
255 Niriella MA, Liyanage IK, Kodisinghe SK, Silva APD, Rajapakshe N, Nanayakkara SD, Luke D, Silva T, Nawarathne M, Peiris RK, Kalubovila UP, Kumarasena SR, Dissanayake VHW, Jayasekara RW, de Silva HJ. Genetic associations of inflammatory bowel disease in a South Asian population. World J Clin Cases 2018; 6(15): 908-915 [PMID: 30568945 DOI: 10.12998/wjcc.v6.i15.908] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
256 Naz S, Khan RA, Giddaluru J, Battu S, Vishwakarma SK, Subahan M, Satti V, Khan N, Khan AA. Transcriptome meta-analysis identifies immune signature comprising of RNA binding proteins in ulcerative colitis patients. Cellular Immunology 2018;334:42-8. [DOI: 10.1016/j.cellimm.2018.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
257 Mak WY, Mak OS, Lee CK, Tang W, Leung WK, Wong MTL, Sze ASF, Li M, Leung CM, Lo FH, Lam BCY, Chan KH, Shan EHS, Tsang SWC, Hui AJ, Chow WH, Chan FKL, Sung JJY, Ng SC. Significant Medical and Surgical Morbidity in Perianal Crohn's Disease: Results from a Territory-Wide Study. J Crohns Colitis. 2018;12:1392-1398. [PMID: 30165543 DOI: 10.1093/ecco-jcc/jjy120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
258 Ge Q, Dong Y, Lin G, Cao Y. Long Noncoding RNA Antisense Noncoding RNA in the INK4 Locus Correlates With Risk, Severity, Inflammation and Infliximab Efficacy in Crohn's Disease. Am J Med Sci 2019;357:134-42. [PMID: 30665494 DOI: 10.1016/j.amjms.2018.10.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
259 Zhang C, Shu W, Zhou G, Lin J, Chu F, Wu H, Liu Z. Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease. Mediators Inflamm 2018;2018:3021863. [PMID: 30595666 DOI: 10.1155/2018/3021863] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
260 Papada E, Forbes A, Amerikanou C, Torović L, Kalogeropoulos N, Tzavara C, Triantafillidis JK, Kaliora AC. Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. Nutrients 2018;10:E1779. [PMID: 30453494 DOI: 10.3390/nu10111779] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
261 Juyal G, Sood A, Midha V, Thelma BK. Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies. J Genet 2018;97:1493-507. [DOI: 10.1007/s12041-018-1015-8] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
262 Min Ho PY, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH, Wee HL, Lim TG, Ong WC. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res 2019;17:107-18. [PMID: 30419638 DOI: 10.5217/ir.2018.00099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
263 Ribaldone D, Pellicano R, Actis G. Pathogenesis of Inflammatory Bowel Disease: Basic Science in the Light of Real-World Epidemiology. GastrointestDisord 2018;1:129-46. [DOI: 10.3390/gidisord1010010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
264 Chen D, Ma J, Luo S, Lu L, Wan X, Ben Q. Effects of Appendectomy on the Onset and Course of Ulcerative Colitis in Chinese Patients. Gastroenterol Res Pract 2018;2018:2927891. [PMID: 30524476 DOI: 10.1155/2018/2927891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
265 Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology. J Can Assoc Gastroenterol 2019;2:S6-S16. [PMID: 31294381 DOI: 10.1093/jcag/gwy054] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 11.4] [Reference Citation Analysis]
266 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
267 Okabayashi S, Kobayashi T, Hibi T. Drug Lag for Inflammatory Bowel Disease Treatments in the East and West. Inflamm Intest Dis 2018;3:25-31. [PMID: 30505839 DOI: 10.1159/000491878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
268 Cai L, Li X, Geng C, Lei X, Wang C. Molecular mechanisms of somatostatin-mediated intestinal epithelial barrier function restoration by upregulating claudin-4 in mice with DSS-induced colitis. American Journal of Physiology-Cell Physiology 2018;315:C527-36. [DOI: 10.1152/ajpcell.00199.2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
269 Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A, Bernstein CN, Leddin D, Tamim H, Stefansson T, Loftus EV Jr, Moum B, Tang W, Ng SC, Gearry R, Sincic B, Bell S, Sands BE, Lakatos PL, Végh Z, Ott C, Kaplan GG, Burisch J, Colombel JF. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries. Gastroenterology 2018;155:1079-1089.e3. [PMID: 29958857 DOI: 10.1053/j.gastro.2018.06.043] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 22.6] [Reference Citation Analysis]
270 Wang P, Hu J, Ghadermarzi S, Raza A, O'Connell D, Xiao A, Ayyaz F, Zhi M, Zhang Y, Parekh NK, Lazarev M, Parian A, Brant SR, Bedine M, Truta B, Hu P, Banerjee R, Hutfless SM. Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA. Dig Dis Sci 2018;63:2703-13. [PMID: 29862485 DOI: 10.1007/s10620-018-5142-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
271 Freudenberg JM, Dunham I, Sanseau P, Rajpal DK. Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands. BMC Bioinformatics 2018;19:345. [PMID: 30285606 DOI: 10.1186/s12859-018-2392-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
272 Nahon S, Ramtohul T, Paupard T, Belhassan M, Clair E, Abitbol V. Evolution in clinical presentation of inflammatory bowel disease over time at diagnosis: a multicenter cohort study. Eur J Gastroenterol Hepatol 2018;30:1125-9. [PMID: 30004906 DOI: 10.1097/MEG.0000000000001201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
273 Yu Y, Zhu S, Li P, Min L, Zhang S. Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis 2018;9:961. [PMID: 30237392 DOI: 10.1038/s41419-018-0982-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
274 Coppell KJ, Galts CP, Huizing FY, Norton JK, Gray AR, Schultz K, Hobbs CE, Aluzaite K, Schultz M. Annual Incidence and Phenotypic Presentation of IBD in Southern New Zealand: An 18-Year Epidemiological Analysis. Inflamm Intest Dis 2018;3:32-9. [PMID: 30505840 DOI: 10.1159/000492615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
275 White LS, Van den Bogaerde J, Kamm M. The gut microbiota: cause and cure of gut diseases. Med J Aust 2018;209:312-7. [PMID: 30257633 DOI: 10.5694/mja17.01067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
276 Nguyen HH, Bechara R, Paterson WG, Hookey LC. Two-year retrospective analysis of patients undergoing direct to procedure flexible sigmoidoscopy investigation with rectal bleeding as a primary complaint. Endosc Int Open 2018;6:E1059-64. [PMID: 30105294 DOI: 10.1055/a-0600-2157] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
277 Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW; IBD Sydney Organisation and the Asia-Pacific Crohn's and Colitis Epidemiology Study (ACCESS) Group. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res 2018;16:409-15. [PMID: 30090040 DOI: 10.5217/ir.2018.16.3.409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
278 Chan SN, Low END, Raja Ali RA, Mokhtar NM. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intest Res 2018;16:374-83. [PMID: 30090036 DOI: 10.5217/ir.2018.16.3.374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
279 Su HJ, Chiu YT, Chiu CT, Lin YC, Wang CY, Hsieh JY, Wei SC. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc. 2019;118:1083-1092. [PMID: 30054112 DOI: 10.1016/j.jfma.2018.07.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
280 Chen XL, Wen Y, Wu ZC, Zhang BP, Hou ZK, Xiao JL, Lin MQ, Hu Y, Wu ZL, Deng JM, Liu FB, Liu TW. Development of a Traditional Chinese Medicine Syndrome-Specific Scale for Ulcerative Colitis: The Large Intestine Dampness-Heat Syndrome Questionnaire. Evid Based Complement Alternat Med 2018;2018:4039019. [PMID: 30108653 DOI: 10.1155/2018/4039019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
281 Shi HY, Ng SC. The state of the art on treatment of Crohn's disease. J Gastroenterol. 2018;53:989-998. [PMID: 29980848 DOI: 10.1007/s00535-018-1479-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
282 Wang Z, Zhu M, Luo C, Zhen Y, Mu J, Zhang W, Ouyang Q, Zhang H. High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease. Sci Rep 2018;8:10018. [PMID: 29968792 DOI: 10.1038/s41598-018-28397-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
283 Zuo T, Kamm MA, Colombel JF, Ng SC. Urbanization and the gut microbiota in health and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2018;15:440-52. [PMID: 29670252 DOI: 10.1038/s41575-018-0003-z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 126] [Article Influence: 26.6] [Reference Citation Analysis]
284 Ong C, Aw MM, Liwanag MJ, Quak SH, Phua KB. Rapid rise in the incidence and clinical characteristics of pediatric inflammatory bowel disease in a South-East Asian cohort in Singapore, 1994-2015. J Dig Dis 2018;19:395-403. [PMID: 29927059 DOI: 10.1111/1751-2980.12641] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
285 Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm 2018;548:408-22. [PMID: 29969711 DOI: 10.1016/j.ijpharm.2018.06.054] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 8.2] [Reference Citation Analysis]
286 Cui G, Yuan A. A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease. Front Med (Lausanne). 2018;5:183. [PMID: 29971235 DOI: 10.3389/fmed.2018.00183] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
287 Lima Martins A, Volpato RA, Zago-Gomes MDP. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterol. 2018;18:87. [PMID: 29914399 DOI: 10.1186/s12876-018-0822-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
288 Kalubowila U, Liyanaarachchi T, Galketiya KB, Rathnayaka P, Piyasena INAP, Tennakoon S, Perera KMP, Pathirana SDMU, Wettewa DB, Ratnayake WRANMP, Raayiz RM, Dissanayaka DMIU. Epidemiology and clinical course of inflammatory bowel disease in the Central Province of Sri Lanka: A hospital-based study. JGH Open. 2018;2:129-133. [PMID: 30483577 DOI: 10.1002/jgh3.12058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
289 Purnamawati K, Ong JA, Deshpande S, Tan WK, Masurkar N, Low JK, Drum CL. The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review. Front Immunol 2018;9:1208. [PMID: 29915581 DOI: 10.3389/fimmu.2018.01208] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
290 Arora U, Kedia S, Garg P, Bopanna S, Jain S, Yadav DP, Goyal S, Gupta V, Sahni P, Pal S, Dash NR, Madhusudhan KS, Sharma R, Makharia G, Ahuja V. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease. Dig Dis Sci 2018;63:1592-9. [PMID: 29611078 DOI: 10.1007/s10620-018-5041-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
291 Chen Z, Chen Q, Du H, Xu L, Wan J. Mesenchymal stem cells and CXC chemokine receptor 4 overexpression improved the therapeutic effect on colitis via mucosa repair. Exp Ther Med 2018;16:821-9. [PMID: 30112037 DOI: 10.3892/etm.2018.6233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
292 Hong M, Ye BD, Yang SK, Jung S, Lee HS, Kim BM, Lee SB, Hong J, Baek J, Park SH, Han B, Li Y, Liu W, Haritunians T, Taylor KD, Rotter JI, Bang SY, Kim TH, McGovern DPB, Liu J, Song K. Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci. J Crohns Colitis 2018;12:730-41. [PMID: 29584801 DOI: 10.1093/ecco-jcc/jjy002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
293 Guan G, Lan S. Implications of Antioxidant Systems in Inflammatory Bowel Disease. Biomed Res Int 2018;2018:1290179. [PMID: 29854724 DOI: 10.1155/2018/1290179] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 10.2] [Reference Citation Analysis]
294 Banerjee R, Pal P, Girish BG, Reddy DN. Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region? Aliment Pharmacol Ther 2018;47:1367-74. [PMID: 29572889 DOI: 10.1111/apt.14617] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
295 Kedia S, Ahuja V. Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition"? Indian J Gastroenterol 2018;37:183-5. [PMID: 29948992 DOI: 10.1007/s12664-018-0852-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
296 Amarapurkar AD, Amarapurkar DN, Rathi P, Sawant P, Patel N, Kamani P, Rawal K, Baijal R, Sonawane A, Narawane N, Kolekar S, Totla N. Risk factors for inflammatory bowel disease: A prospective multi-center study. Indian J Gastroenterol 2018;37:189-95. [PMID: 29987750 DOI: 10.1007/s12664-018-0850-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
297 Song KH, Kim ES, Lee YJ, Jang BI, Kim KO, Kwak SG, Lee HS; Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis. Intest Res 2018;16:216-22. [PMID: 29743834 DOI: 10.5217/ir.2018.16.2.216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
298 Kedia S, Limdi JK, Ahuja V. Management of inflammatory bowel disease in older persons: evolving paradigms. Intest Res 2018;16:194-208. [PMID: 29743832 DOI: 10.5217/ir.2018.16.2.194] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
299 Wu XR, Liu HS, Shi XY, Zhou WX, Jiang ZN, Huang Y, Karamchandani DM, Goldblum JR, Xiao SY, Zhu HF, Feely MM, Collinsworth AL, Esnakula A, Xie H, Shen B, Lan P, Liu XL. Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists. Gastroenterol Res Pract 2018;2018:8715263. [PMID: 29849600 DOI: 10.1155/2018/8715263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
300 Yu HC, Chen TP, Chang YC. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database. J Dent Sci 2018;13:242-7. [PMID: 30895127 DOI: 10.1016/j.jds.2018.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
301 Song EM, Kim N, Lee SH, Chang K, Hwang SW, Park SH, Yang DH, Byeon JS, Myung SJ, Yang SK, Ye BD. Clinical characteristics and long-term prognosis of elderly-onset Crohn's disease. Scand J Gastroenterol 2018;53:417-25. [PMID: 29457917 DOI: 10.1080/00365521.2018.1437927] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
302 Kim JW, Lee CK, Rhee SY, Oh CH, Shim JJ, Kim HJ. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study. J Gastroenterol Hepatol 2018;33:847-54. [PMID: 29055148 DOI: 10.1111/jgh.14027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
303 Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J, Higgins PD, Kotze PG, Meissner J, O'Connor M, Ran ZH, Siegel CA, Terry H, van Deen WK, van der Woude CJ, Weaver A, Yang SK, Sands BE, Vermeire S, Travis SP. Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus. J Crohns Colitis 2018;12:408-18. [PMID: 29216349 DOI: 10.1093/ecco-jcc/jjx161] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 16.2] [Reference Citation Analysis]
304 Mancabelli L, Milani C, Lugli GA, Turroni F, Cocconi D, van Sinderen D, Ventura M. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiol Ecol 2017;93. [PMID: 29126267 DOI: 10.1093/femsec/fix153] [Cited by in Crossref: 110] [Cited by in F6Publishing: 117] [Article Influence: 22.0] [Reference Citation Analysis]
305 Zhang B, Liu Y, Lan X, Xu X, Zhang X, Li X, Zhao Y, Li G, Du C, Lu S, Wang H. Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice. J Transl Med 2018;16:71. [PMID: 29554971 DOI: 10.1186/s12967-018-1441-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
306 Aardoom MA, Joosse ME, de Vries ACH, Levine A, de Ridder L. Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis 2018;24:732-41. [PMID: 29522170 DOI: 10.1093/ibd/izx104] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
307 Chen CH, Lin CL, Kao CH. Association between Inflammatory Bowel Disease and Cholelithiasis: A Nationwide Population-Based Cohort Study. Int J Environ Res Public Health 2018;15:E513. [PMID: 29538289 DOI: 10.3390/ijerph15030513] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
308 Lee WS, Tee CW, Koay ZL, Wong TS, Zahraq F, Foo HW, Ong SY, Wong SY, Ng RT. Quality indicators in pediatric colonoscopy in a low-volume center: Implications for training. World J Gastroenterol 2018; 24(9): 1013-1021 [PMID: 29531465 DOI: 10.3748/wjg.v24.i9.1013] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
309 Yoon JY, Shin JE, Park SH, Park DI, Cha JM. Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life. Gut Liver 2017;11:370-6. [PMID: 28208008 DOI: 10.5009/gnl16422] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
310 Eom T, Kim YS, Choi CH, Sadowsky MJ, Unno T. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. J Microbiol 2018;56:189-98. [PMID: 29492876 DOI: 10.1007/s12275-018-8049-8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 12.8] [Reference Citation Analysis]
311 Wang HH, He Y, Wang HX, Liao CL, Peng Y, Tao LJ, Zhang W, Yang HX. Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2018; 24(8): 941-948 [PMID: 29491687 DOI: 10.3748/wjg.v24.i8.941] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
312 Wu WKK, Sun R, Zuo T, Tian Y, Zeng Z, Ho J, Wu JCY, Chan FKL, Chan MTV, Yu J, Sung JJY, Wong SH, Wang MH, Ng SC. A novel susceptibility locus in MST1 and gene-gene interaction network for Crohn's disease in the Chinese population. J Cell Mol Med 2018;22:2368-77. [PMID: 29441677 DOI: 10.1111/jcmm.13530] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
313 Zhou Y, Ou Z, Tang X, Zhou Y, Xu H, Wang X, Li K, He J, Du Y, Wang H, Chen Y, Nie Y. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome. J Cell Mol Med 2018;22:2263-71. [PMID: 29411528 DOI: 10.1111/jcmm.13508] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
314 Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clin Gastroenterol Hepatol 2018;16:190-197.e11. [PMID: 28603049 DOI: 10.1016/j.cgh.2017.05.047] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 12.4] [Reference Citation Analysis]
315 Everhov ÅH, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, Söderling J, Ekbom A, Neovius M, Ludvigsson JF, Askling J, Olén O. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology 2018;154:518-528.e15. [PMID: 29102619 DOI: 10.1053/j.gastro.2017.10.034] [Cited by in Crossref: 120] [Cited by in F6Publishing: 124] [Article Influence: 24.0] [Reference Citation Analysis]
316 Zhou Y, Xu ZZ, He Y, Yang Y, Liu L, Lin Q, Nie Y, Li M, Zhi F, Liu S, Amir A, González A, Tripathi A, Chen M, Wu GD, Knight R, Zhou H, Chen Y. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems 2018;3:e00188-17. [PMID: 29404425 DOI: 10.1128/mSystems.00188-17] [Cited by in Crossref: 127] [Cited by in F6Publishing: 137] [Article Influence: 25.4] [Reference Citation Analysis]
317 Aniwan S, Tremaine WJ, Raffals LE, Kane SV, Loftus EV Jr. Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study. J Crohns Colitis 2018;12:137-44. [PMID: 29029150 DOI: 10.1093/ecco-jcc/jjx135] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
318 Weimers P, Munkholm P. The Natural History of IBD: Lessons Learned. Curr Treat Options Gastroenterol 2018;16:101-11. [PMID: 29359275 DOI: 10.1007/s11938-018-0173-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
319 Misra R, Faiz O, Munkholm P, Burisch J, Arebi N. Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups. World J Gastroenterol 2018; 24(3): 424-437 [PMID: 29391765 DOI: 10.3748/wjg.v24.i3.424] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
320 Nie JY, Zhao Q. Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies. Medicine (Baltimore) 2017;96:e9070. [PMID: 29245319 DOI: 10.1097/MD.0000000000009070] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
321 Liu P, Li R, Bao C, Wei Y, Fan Y, Liu Y, Wang G, Wu H, Qin W. Altered topological patterns of brain functional networks in Crohn’s disease. Brain Imaging and Behavior 2018;12:1466-78. [DOI: 10.1007/s11682-017-9814-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
322 Mak LY, Ng SC, Wong IOL, Li MKK, Lo FH, Wong MTL, Leung CM, Tsang SWC, Chan KH, Sze SF, Shan EHS, Lam BCY, Hui AJ, Hung IFN, Leung WK. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis. J Gastroenterol Hepatol 2018;33:141-9. [PMID: 28475813 DOI: 10.1111/jgh.13817] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
323 Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol 2018;15:39-49. [PMID: 29018271 DOI: 10.1038/nrgastro.2017.136] [Cited by in Crossref: 374] [Cited by in F6Publishing: 328] [Article Influence: 74.8] [Reference Citation Analysis]
324 Chen M, Shen B. Overview of Diagnosis and Medical Treatment of Inflammatory Bowel Diseases. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00001-4] [Reference Citation Analysis]
325 Verstockt B, Verstockt S, Cleynen I. Genetic Influences on the Development of Fibrosis in Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_3] [Reference Citation Analysis]
326 Ng WK, Ng SC. Epidemiology and Natural History of Fibrostenosing Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
327 Pyo JH, Kim YS, Park YS, Kim Y. Differential Diagnosis of Inflammatory Bowel Disease: Endoscopic Findings and Diagnosis of Intestinal Tuberculosis. Advances in Endoscopy in Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-4-431-56018-0_10] [Reference Citation Analysis]
328 Xu L, Rao P, Liu X, Zeng Z. A New Immunofluorescence Assay for Fecal Calprotectin Distinguishes Inflammatory Bowel Disease from Functional Bowel Disease. OJGas 2018;08:405-414. [DOI: 10.4236/ojgas.2018.811042] [Reference Citation Analysis]
329 Chan WPW, Ooi CJ, Soetikno R. Endoscopy in Inflammatory Bowel Disease: Asian Perspective—Singapore. Advances in Endoscopy in Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-4-431-56018-0_27] [Reference Citation Analysis]
330 Ding X, Li D, Li M, Tian D, Yu H, Yu Q. Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation. Int J Mol Med 2018;41:1224-32. [PMID: 29286110 DOI: 10.3892/ijmm.2017.3347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
331 Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World J Gastroenterol 2017; 23(46): 8235-8247 [PMID: 29290660 DOI: 10.3748/wjg.v23.i46.8235] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
332 Zhang Y, Tian L, Sleiman P, Ghosh S, Hakonarson H; International IBD Genetics Consortium. Bayesian analysis of genome-wide inflammatory bowel disease data sets reveals new risk loci. Eur J Hum Genet 2018;26:265-74. [PMID: 29203833 DOI: 10.1038/s41431-017-0041-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
333 Kamm MA. Rapid changes in epidemiology of inflammatory bowel disease. The Lancet 2017;390:2741-2. [DOI: 10.1016/s0140-6736(17)32669-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
334 Sun CM, Wu J, Zhang H, Shi G, Chen ZT. Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn’s disease. World J Gastroenterol 2017; 23(44): 7888-7898 [PMID: 29209130 DOI: 10.3748/wjg.v23.i44.7888] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
335 Xu S, Zou H, Zhang H, Zhu S, Zhou R, Li J. Investigation of inflammatory bowel disease risk factors in 4 families in central China. Exp Ther Med. 2018;15:1367-1375. [PMID: 29399122 DOI: 10.3892/etm.2017.5582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
336 So J, Tang W, Leung WK, Li M, Lo FH, Wong MTL, Sze ASF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Lam TY, Lam V, Lee TW, Lo HHH, Tang CM, Wong CL, Wu JCY, Chan FKL, Sung JJY, Harbord M, Ng SC. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study. Inflamm Bowel Dis 2017;23:2061-8. [PMID: 28991855 DOI: 10.1097/MIB.0000000000001240] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
337 Bernstein CN. Large Registry Epidemiology in IBD. Inflamm Bowel Dis 2017;23:1941-9. [PMID: 28991858 DOI: 10.1097/MIB.0000000000001279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
338 Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN. Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2017;46:780-9. [PMID: 28892171 DOI: 10.1111/apt.14291] [Cited by in Crossref: 97] [Cited by in F6Publishing: 84] [Article Influence: 16.2] [Reference Citation Analysis]
339 Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol 2017; 23(37): 6788-6801 [PMID: 29085223 DOI: 10.3748/wjg.v23.i37.6788] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
340 Lee DW, Koo JS, Choe JW, Suh SJ, Kim SY, Hyun JJ, Jung SW, Jung YK, Yim HJ, Lee SW. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol 2017; 23(35): 6474-6481 [PMID: 29085197 DOI: 10.3748/wjg.v23.i35.6474] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
341 Aleksandrova K, Romero-Mosquera B, Hernandez V. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Nutrients 2017;9:E962. [PMID: 28867793 DOI: 10.3390/nu9090962] [Cited by in Crossref: 85] [Cited by in F6Publishing: 89] [Article Influence: 14.2] [Reference Citation Analysis]
342 Niewiadomski O, Studd C, Wilson J, Williams J, Hair C, Knight R, Prewett E, Dabkowski P, Alexander S, Allen B, Dowling D, Connell W, Desmond P, Bell S. Influence of food and lifestyle on the risk of developing inflammatory bowel disease. Intern Med J 2016;46:669-76. [PMID: 27059169 DOI: 10.1111/imj.13094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 8.2] [Reference Citation Analysis]
343 Yoshioka S, Takedatsu H, Fukunaga S, Kuwaki K, Yamasaki H, Yamauchi R, Mori A, Kawano H, Yanagi T, Mizuochi T, Ushijima K, Mitsuyama K, Tsuruta O, Torimura T. Study to determine guidelines for pediatric colonoscopy. World J Gastroenterol 2017; 23(31): 5773-5779 [PMID: 28883703 DOI: 10.3748/wjg.v23.i31.5773] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
344 Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon. 2018;64:20-57. [PMID: 28826742 DOI: 10.1016/j.disamonth.2017.07.001] [Cited by in Crossref: 190] [Cited by in F6Publishing: 209] [Article Influence: 31.7] [Reference Citation Analysis]
345 Hwang SW, Seo H, Kim GU, Song EM, Seo M, Park SH, Kwon E, Lee HS, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH, Yang SK. Underestimation of Smoking Rates in an East Asian Population with Crohn's Disease. Gut Liver 2017;11:73-8. [PMID: 27728967 DOI: 10.5009/gnl16194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
346 Zhou M, He J, Shen Y, Zhang C, Wang J, Chen Y. New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. Biomed Res Int 2017;2017:8201672. [PMID: 28831399 DOI: 10.1155/2017/8201672] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
347 Jung YS, Han M, Kim WH, Park S, Cheon JH. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study. Dig Dis Sci 2017;62:2102-12. [PMID: 28593437 DOI: 10.1007/s10620-017-4640-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
348 Wang R, Gu X, Dai W, Ye J, Lu F, Chai Y, Fan G, Gonzalez FJ, Duan G, Qi Y. A lipidomics investigation into the intervention of celastrol in experimental colitis. Mol Biosyst 2016;12:1436-44. [PMID: 27021137 DOI: 10.1039/c5mb00864f] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
349 Cha JM, Park DI, Park SH, Shin JE, Kim WS, Yang SK. Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients. J Korean Med Sci 2017;32:85-94. [PMID: 27914136 DOI: 10.3346/jkms.2017.32.1.85] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
350 Goh KL. Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). J Clin Gastroenterol 2017;51:479-85. [PMID: 28591070 DOI: 10.1097/MCG.0000000000000847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
351 Dai SX, Gu HX, Lin QY, Wu YK, Wang XY, Huang SZ, Xing TS, Chen MH, Zhang QF, Zheng ZW, Sha WH. Decreased CD8+CD28+/CD8+CD28- T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease. Medicine (Baltimore) 2017;96:e7247. [PMID: 28658115 DOI: 10.1097/MD.0000000000007247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
352 Tian T, Wang Z, Zhang J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. Oxid Med Cell Longev 2017;2017:4535194. [PMID: 28744337 DOI: 10.1155/2017/4535194] [Cited by in Crossref: 213] [Cited by in F6Publishing: 246] [Article Influence: 35.5] [Reference Citation Analysis]
353 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Intest Res. 2017;15:266-284. [PMID: 28670225 DOI: 10.5217/ir.2017.15.3.266] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
354 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res 2017;15:285-310. [PMID: 28670226 DOI: 10.5217/ir.2017.15.3.285] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
355 Yamamoto-Furusho JK. Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies. Pharmgenomics Pers Med 2017;10:197-204. [PMID: 28603427 DOI: 10.2147/PGPM.S109648] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
356 Zeng L, Hu S, Chen P, Wei W, Tan Y. Macronutrient Intake and Risk of Crohn's Disease: Systematic Review and Dose-Response Meta-Analysis of Epidemiological Studies. Nutrients. 2017;9:500. [PMID: 28505133 DOI: 10.3390/nu9050500] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
357 Dai SX, Gu HX, Lin QY, Huang SZ, Xing TS, Zhang QF, Wu G, Chen MH, Tan WE, Jian HJ, Zheng ZW, Zhong T, Zhang MH, Cheng XF, Huang P, Liao GJ, Sha WH. CD8+CD28+/CD8+CD28- T cell equilibrium can predict the active stage for patients with inflammatory bowel disease. Clin Res Hepatol Gastroenterol 2017;41:693-702. [PMID: 28502591 DOI: 10.1016/j.clinre.2017.03.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
358 Ji CC, Takano S. Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease. Intest Res 2017;15:182-6. [PMID: 28522947 DOI: 10.5217/ir.2017.15.2.182] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
359 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 11.5] [Reference Citation Analysis]
360 Naidu J, Wong Zh, Palaniappan Sh, Ngiu ChS, Yaacob NY, Abdul Hamid H, Hikmah Elias M, Mokhtar NM, Raja Ali RA. Radiation Exposure in Patients with Inflammatory Bowel Disease: a Fourteen-Year Review at a Tertiary Care Centre in Malaysia. Asian Pac J Cancer Prev 2017;18:933-9. [PMID: 28545190 DOI: 10.22034/APJCP.2017.18.4.933] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
361 Lophaven SN, Lynge E, Burisch J. The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study. Aliment Pharmacol Ther 2017;45:961-72. [PMID: 28229470 DOI: 10.1111/apt.13971] [Cited by in Crossref: 85] [Cited by in F6Publishing: 62] [Article Influence: 14.2] [Reference Citation Analysis]
362 Bao X, Feng Z, Yao J, Li T, Yin Y. Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm. 2017;2017:6869259. [PMID: 28392631 DOI: 10.1155/2017/6869259] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
363 Haskey N, Gibson DL. An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease. Nutrients 2017;9:E259. [PMID: 28287412 DOI: 10.3390/nu9030259] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 9.0] [Reference Citation Analysis]
364 Sturm A, Maaser C, Mendall M, Karagiannis D, Karatzas P, Ipenburg N, Sebastian S, Rizzello F, Limdi J, Katsanos K, Schmidt C, Jeuring S, Colombo F, Gionchetti P. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly. J Crohns Colitis 2017;11:263-73. [PMID: 27797918 DOI: 10.1093/ecco-jcc/jjw188] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
365 Zhu Z, Li M, Shu X, Bai A, Long S, Liu D, Lu N, Zhu X, Liao W. Thalidomide is a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients. Clinics and Research in Hepatology and Gastroenterology 2017;41:210-6. [DOI: 10.1016/j.clinre.2016.09.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
366 Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology 2017;152:313-321.e2. [PMID: 27793607 DOI: 10.1053/j.gastro.2016.10.020] [Cited by in Crossref: 528] [Cited by in F6Publishing: 542] [Article Influence: 88.0] [Reference Citation Analysis]
367 Vegh Z, Kurti Z, Lakatos PL. Epidemiology of inflammatory bowel diseases from west to east. J Dig Dis 2017;18:92-8. [PMID: 28102560 DOI: 10.1111/1751-2980.12449] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 8.7] [Reference Citation Analysis]
368 Subramanian S, Ekbom A, Rhodes JM. Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD? Gut 2017;66:362-81. [PMID: 27802156 DOI: 10.1136/gutjnl-2016-312673] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
369 Yang SK. How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective. Inflamm Intest Dis. 2017;2:95-101. [PMID: 30018960 DOI: 10.1159/000454712] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
370 Ananthakrishnan AN. The New Face of IBD. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
371 Wang F, Lin X, Zhao Q, Li J. Fat intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studies. J Gastroenterol Hepatol 2017;32:19-27. [PMID: 27097307 DOI: 10.1111/jgh.13416] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
372 Coward S, Kaplan GG. IBD in the New World, Old World, and Your World. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
373 Targownik LE, Bernstein CN. The Economics of Inflammatory Bowel Disease. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_21] [Reference Citation Analysis]
374 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
375 Lee WS, Ng RT, Chan KW, Lau YL. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. World J Gastroenterol 2016; 22(48): 10653-10662 [PMID: 28082818 DOI: 10.3748/wjg.v22.i48.10653] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
376 Han M, Jung YS, Kim WH, Cheon JH, Park S. Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study. J Gastroenterol 2017;52:920-8. [PMID: 28028610 DOI: 10.1007/s00535-016-1300-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
377 Konkel L. Inflammatory Bowel Disease in Asia: A Second Chance at Uncovering Environmental Factors. Environ Health Perspect 2016;124:A49-54. [PMID: 26930697 DOI: 10.1289/ehp.124-A49] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
378 Chen RB. Self-management for patients with inflammatory bowel disease in a gastroenterology ward in China: a best practice implementation project. JBI Database System Rev Implement Rep 2016;14:271-7. [PMID: 27941520 DOI: 10.11124/JBISRIR-2016-003180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
379 Moran C, Sheehan D, Shanahan F. The Changing Phenotype of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:1619053. [PMID: 28050166 DOI: 10.1155/2016/1619053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
380 Yang SK, Hong M, Oh H, Low HQ, Jung S, Ahn S, Kim Y, Baek J, Lee CH, Kim E, Kim KM, Ye BD, Kim KJ, Park SH, Lee HS, Lee I, Shin HD, Han B, McGovern DP, Liu J, Song K. Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans. Gastroenterology 2016;151:1096-1099.e4. [PMID: 27569725 DOI: 10.1053/j.gastro.2016.08.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
381 Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389:1741-1755. [PMID: 27914655 DOI: 10.1016/s0140-6736(16)31711-1] [Cited by in Crossref: 955] [Cited by in F6Publishing: 999] [Article Influence: 136.4] [Reference Citation Analysis]
382 Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, Naganuma M, Sato T, Takada T, Tsuji H, Kushiro A, Nomoto K, Kanai T. A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients. Inflamm Bowel Dis 2016;22:2802-10. [PMID: 27824645 DOI: 10.1097/MIB.0000000000000972] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 11.4] [Reference Citation Analysis]
383 Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756-1770. [PMID: 27914657 DOI: 10.1016/s0140-6736(16)32126-2] [Cited by in Crossref: 1306] [Cited by in F6Publishing: 1116] [Article Influence: 186.6] [Reference Citation Analysis]
384 Zhang JZ, Bao CH, Shi Z, Weng ZJ, Wang XM, Wu LY, Wu HG. Role of intestinal microbiota in pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(33): 4505-4513 [DOI: 10.11569/wcjd.v24.i33.4505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
385 Zhang TY, Lin Y, Fan R, Hu SR, Cheng MM, Zhang MC, Hong LW, Zhou XL, Wang ZT, Zhong J. Potential model for differential diagnosis between Crohn's disease and primary intestinal lymphoma. World J Gastroenterol 2016; 22(42): 9411-9418 [PMID: 27895429 DOI: 10.3748/wjg.v22.i42.9411] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
386 Chan HC, Ng SC. Emerging biologics in inflammatory bowel disease. J Gastroenterol. 2017;52:141-150. [PMID: 27832357 DOI: 10.1007/s00535-016-1283-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
387 Kurti Z, Vegh Z, Golovics PA, Fadgyas-Freyler P, Gecse KB, Gonczi L, Gimesi-Orszagh J, Lovasz BD, Lakatos PL. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database. Dig Liver Dis 2016;48:1302-7. [PMID: 27481587 DOI: 10.1016/j.dld.2016.07.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
388 Bernstein CN, Eliakim A, Fedail S, Fried M, Gearry R, Goh KL, Hamid S, Khan AG, Khalif I, Ng SC, Ouyang Q, Rey JF, Sood A, Steinwurz F, Watermeyer G, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J Clin Gastroenterol 2016;50:803-18. [PMID: 27741097 DOI: 10.1097/MCG.0000000000000660] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 12.9] [Reference Citation Analysis]
389 Wu CH, Chung PI, Wu CY, Chen YT, Chiu YW, Chang YT, Liu HN. Comorbid autoimmune diseases in patients with sarcoidosis: A nationwide case-control study in Taiwan. J Dermatol 2017;44:423-30. [PMID: 27786368 DOI: 10.1111/1346-8138.13654] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
390 Degasperi E, Caprioli F, El Sherif O, Back D, Colombo M, Aghemo A. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection. Expert Rev Gastroenterol Hepatol. 2016;10:1373-1383. [PMID: 27718758 DOI: 10.1080/17474124.2016.1246181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
391 Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An overview of the bacterial contribution to Crohn disease pathogenesis. Journal of Medical Microbiology 2016;65:1049-59. [DOI: 10.1099/jmm.0.000331] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
392 Yu Q, Mao R, Lian L, Ng SC, Zhang S, Chen Z, Zhang Y, Qiu Y, Chen B, He Y, Zeng Z, Ben-Horin S, Song X, Chen M. Surgical management of inflammatory bowel disease in China: a systematic review of two decades. Intest Res 2016;14:322-32. [PMID: 27799883 DOI: 10.5217/ir.2016.14.4.322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
393 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
394 Wang F, Feng J, Gao Q, Ma M, Lin X, Liu J, Li J, Zhao Q. Carbohydrate and protein intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studies. Clin Nutr. 2017;36:1259-1265. [PMID: 27776925 DOI: 10.1016/j.clnu.2016.10.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
395 Ray G. Inflammatory bowel disease in India - Past, present and future. World J Gastroenterol 2016; 22(36): 8123-8136 [PMID: 27688654 DOI: 10.3748/wjg.v22.i36.8123] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
396 Su HY, Gupta V, Day AS, Gearry RB. Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand. Inflamm Bowel Dis 2016;22:2238-44. [PMID: 27482976 DOI: 10.1097/MIB.0000000000000829] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
397 Li G, Ren J, Wang G, Hu Q, Wu Q, Wu X, Li R, Guo K, Li Y, Gu G, Ren H, Hong Z, Li J. Disease-related knowledge and smoking behavior of patients with Crohn's disease. Dig Liver Dis 2016;48:1006-11. [PMID: 27289332 DOI: 10.1016/j.dld.2016.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
398 Ko MK, Ng SC, Mak LY, Li MK, Lo FH, Ng CK, Lao WC, Tsang S, Chan KH, Hui YT, Shan EH, Loo CK, Hui AJ, To WP, Hung IF, Leung WK. Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis. J Dig Dis 2016;17:610-7. [PMID: 27533786 DOI: 10.1111/1751-2980.12397] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
399 Chan HC, Wong VW, Wong GL, Tang W, Wu JC, Ng SC. Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region. BMC Gastroenterol. 2016;16:100. [PMID: 27549153 DOI: 10.1186/s12876-016-0516-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
400 Li Y, Qian JM. The Challenge of Inflammatory Bowel Disease Diagnosis in Asia. Inflamm Intest Dis. 2016;1:159-164. [PMID: 29922672 DOI: 10.1159/000448384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
401 Lee HA, Suk JY, Choi SY, Kim ER, Kim YH, Lee CK, Huh KC, Lee KM, Park DI. Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data. Gut Liver 2015;9:756-60. [PMID: 25963086 DOI: 10.5009/gnl14338] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
402 Wang M, Liang C, Hu H, Zhou L, Xu B, Wang X, Han Y, Nie Y, Jia S, Liang J, Wu K. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Sci Rep 2016;6:30696. [PMID: 27488951 DOI: 10.1038/srep30696] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 8.7] [Reference Citation Analysis]
403 Ng SC, Leung WK, Shi HY, Li MK, Leung CM, Ng CK, Lo FH, Hui YT, Tsang SW, Chan YK, Loo CK, Chan KH, Hui AJ, Chow WH, Harbord M, Ching JY, Lee M, Chan V, Tang W, Hung IF, Ho J, Lao WC, Wong MT, Sze SF, Shan EH, Lam BC, Tong RW, Mak LY, Wong SH, Wu JC, Chan FK, Sung JJ. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong. Inflamm Bowel Dis 2016;22:1954-60. [PMID: 27416041 DOI: 10.1097/MIB.0000000000000846] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 10.9] [Reference Citation Analysis]
404 John ES, Katz K, Saxena M, Chokhavatia S, Katz S. Management of Inflammatory Bowel Disease in the Elderly. Curr Treat Options Gastroenterol. 2016;14:285-304. [PMID: 27387455 DOI: 10.1007/s11938-016-0099-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
405 Wang SL, Zhao SB, Fang J, Ma D, Fu HY, Li ZS, Bai Y. Role of stress and intestinal barrier dysfunction in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(21): 3248-3254 [DOI: 10.11569/wcjd.v24.i21.3248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
406 GI Disease Nutrition Management: Inflammatory Bowel Disease. Outpatient Nutrition Care and Home Nutrition Support 2016. [DOI: 10.1201/9781315381664-5] [Reference Citation Analysis]
407 Lui RNS, Ng SC. The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West? Inflamm Intest Dis 2016;1:78-84. [PMID: 29922661 DOI: 10.1159/000446625] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
408 Torres J, Burisch J, Riddle M, Dubinsky M, Colombel JF. Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities. Gut 2016;65:1061-9. [PMID: 27196600 DOI: 10.1136/gutjnl-2016-311785] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
409 Nakase H, Keum B, Ye BD, Park SJ, Koo HS, Eun CS. Treatment of inflammatory bowel disease in Asia: The results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016;14:231-239. [PMID: 27433145 DOI: 10.5217/ir.2016.14.3.231] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
410 Kim JY, Park DI, Han DS, Huh KC, Lee CK, Shin JE, Kim JH, Kim YS, Jung Y, Jung SA, Song HJ, Jang HJ, Kim YH, Hong SN. Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study. Korean J Intern Med 2017;32:69-78. [PMID: 27338135 DOI: 10.3904/kjim.2014.262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
411 Simian D, Fluxá D, Flores L, Lubascher J, Ibáñez P, Figueroa C, Kronberg U, Acuña R, Moreno M, Quera R. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol 2016; 22(22): 5267-5275 [PMID: 27298570 DOI: 10.3748/wjg.v22.i22.5267] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
412 Verstockt B, Cleynen I. Genetic Influences on the Development of Fibrosis in Crohn's Disease. Front Med (Lausanne) 2016;3:24. [PMID: 27303667 DOI: 10.3389/fmed.2016.00024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
413 Lin TY, Chen YG, Lin CL, Huang WS, Kao CH. Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease: A Nationwide Cohort Study. Medicine (Baltimore). 2015;94:e2381. [PMID: 26717386 DOI: 10.1097/md.0000000000002381] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
414 Kabbani TA, Koutroubakis IE, Schoen RE, Ramos-Rivers C, Shah N, Swoger J, Regueiro M, Barrie A, Schwartz M, Hashash JG, Baidoo L, Dunn MA, Binion DG. Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol 2016;111:712-9. [PMID: 26952579 DOI: 10.1038/ajg.2016.53] [Cited by in Crossref: 127] [Cited by in F6Publishing: 128] [Article Influence: 18.1] [Reference Citation Analysis]
415 Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111-119. [PMID: 27175111 DOI: 10.5217/ir.2016.14.2.111] [Cited by in Crossref: 202] [Cited by in F6Publishing: 212] [Article Influence: 28.9] [Reference Citation Analysis]
416 Wu KC, Ran ZH, Gao X, Chen M, Zhong J, Sheng JQ, Kamm MA, Travis S, Wallace K, Mostafa NM, Shapiro M, Li Y, Thakkar RB, Robinson AM. Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease. Intest Res 2016;14:152-63. [PMID: 27175116 DOI: 10.5217/ir.2016.14.2.152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
417 Ohtsuka K, Takenaka K, Kitazume Y, Fujii T, Matsuoka K, Kimura M, Nagaishi T, Watanabe M. Magnetic resonance enterography for the evaluation of the deep small intestine in Crohn's disease. Intest Res 2016;14:120-6. [PMID: 27175112 DOI: 10.5217/ir.2016.14.2.120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
418 Costello SP, Ghaly S, Beswick L, Pudipeddi A, Agarwal A, Sechi A, O'Connor S, Connor SJ, Sparrow MP, Bampton P, Walsh AJ, Andrews JM; Australian Inflammatory Bowel Disease Association (AIBDA). Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients. Intern Med J 2015;45:659-66. [PMID: 25732268 DOI: 10.1111/imj.12732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
419 Wang H, Chao K, Ng SC, Bai AH, Yu Q, Yu J, Li M, Cui Y, Chen M, Hu JF. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Genome Biol. 2016;17:58. [PMID: 27029486 DOI: 10.1186/s13059-016-0901-8] [Cited by in Crossref: 106] [Cited by in F6Publishing: 115] [Article Influence: 15.1] [Reference Citation Analysis]
420 Eun CS, Kwak MJ, Han DS, Lee AR, Park DI, Yang SK, Kim YS, Kim JF. Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients? BMC Gastroenterol 2016;16:28. [PMID: 26922889 DOI: 10.1186/s12876-016-0437-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
421 Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016; 7(1): 112-125 [PMID: 26855817 DOI: 10.4292/wjgpt.v7.i1.112] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
422 Lee S, Ye BD. Are there interregional differences in the epidemiology and clinical characteristics of Crohn's disease in the Asia-Pacific region? Intest Res 2016;14:2-4. [PMID: 26884728 DOI: 10.5217/ir.2016.14.1.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
423 Zhai H, Liu A, Huang W, Liu X, Feng S, Wu J, Yao Y, Wang C, Li Q, Hao Q, Hu J, Zhang S. Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China. BMC Gastroenterol 2016;16:2. [PMID: 26754840 DOI: 10.1186/s12876-015-0405-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
424 Kaplan GG, Jess T. The Changing Landscape of Inflammatory Bowel Disease: East Meets West. Gastroenterology 2016;150:24-6. [PMID: 26592321 DOI: 10.1053/j.gastro.2015.11.029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
425 Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, Ling KL, Lim WC, Thia KT, Wei SC, Leung WK, Koh PK, Gearry RB, Goh KL, Ouyang Q, Sollano J, Manatsathit S, de Silva HJ, Rerknimitr R, Pisespongsa P, Abu Hassan MR, Sung J, Hibi T, Boey CC, Moran N, Leong RW; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1). J Gastroenterol Hepatol 2016;31:45-55. [PMID: 25819140 DOI: 10.1111/jgh.12956] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 11.4] [Reference Citation Analysis]
426 Ng SC, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm MA, Hu P, de Silva HJ, Niriella MA, Udara WS, Ong D, Ling KL, Ooi CJ, Hilmi I, Lee Goh K, Ouyang Q, Wang YF, Wu K, Wang X, Pisespongsa P, Manatsathit S, Aniwan S, Limsrivilai J, Gunawan J, Simadibrata M, Abdullah M, Tsang SW, Lo FH, Hui AJ, Chow CM, Yu HH, Li MF, Ng KK, Ching JY, Chan V, Wu JC, Chan FK, Chen M, Sung JJ; Asia-Pacific Crohn’s and Colitis Epidemiology Study (ACCESS) Group. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology 2016;150:86-95.e3; quiz e13-4. [PMID: 26385074 DOI: 10.1053/j.gastro.2015.09.005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 11.3] [Reference Citation Analysis]
427 Moon CM, Jung SA, Kim SE, Song HJ, Jung Y, Ye BD, Cheon JH, Kim YS, Kim YH, Kim JS, Han DS; CONNECT study group. Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study. PLoS One. 2015;10:e0144390. [PMID: 26647084 DOI: 10.1371/journal.pone.0144390] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
428 Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015;12:720-7. [PMID: 26323879 DOI: 10.1038/nrgastro.2015.150] [Cited by in Crossref: 1157] [Cited by in F6Publishing: 1042] [Article Influence: 144.6] [Reference Citation Analysis]
429 Li JW, Tan MT, Ang TL, Teo EK. Chemoprevention trials of GI cancers in Asia. Best Pract Res Clin Gastroenterol 2015;29:967-78. [PMID: 26651257 DOI: 10.1016/j.bpg.2015.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
430 Hanauer SB, Podolsky DK. Ulcerative Colitis. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch71] [Reference Citation Analysis]
431 Ananthakrishnan AN, Xavier RJ, Podolsky DK. Inflammatory Bowel Diseases: Pathogenesis. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch70] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
432 Zhang FM, Xu CF, Shan GD, Chen HT, Xu GQ. Is gallstone disease associated with inflammatory bowel diseases? A meta-analysis. J Dig Dis 2015;16:634-41. [PMID: 26332254 DOI: 10.1111/1751-2980.12286] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
433 Niewiadomski O, Studd C, Hair C, Wilson J, Ding NS, Heerasing N, Ting A, McNeill J, Knight R, Santamaria J, Prewett E, Dabkowski P, Dowling D, Alexander S, Allen B, Popp B, Connell W, Desmond P, Bell S. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity. J Gastroenterol Hepatol 2015;30:1346-53. [PMID: 25867770 DOI: 10.1111/jgh.12967] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 7.5] [Reference Citation Analysis]
434 Zhao C, Bao C, Li J, Zhu Y, Wang S, Yang L, Shi Y, Liu H, Dou C, Ding G, Wang X, Wu H. Moxibustion and Acupuncture Ameliorate Crohn's Disease by Regulating the Balance between Th17 and Treg Cells in the Intestinal Mucosa. Evid Based Complement Alternat Med 2015;2015:938054. [PMID: 26347488 DOI: 10.1155/2015/938054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
435 Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 2015;50:942-51. [PMID: 25687629 DOI: 10.3109/00365521.2015.1014407] [Cited by in Crossref: 221] [Cited by in F6Publishing: 211] [Article Influence: 27.6] [Reference Citation Analysis]
436 Kuo CJ, Yu KH, See LC, Chiu CT, Su MY, Hsu CM, Kuo CF, Chiou MJ, Liu JR, Wang HW. The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study. Dig Dis Sci 2015;60:2454-62. [PMID: 25837597 DOI: 10.1007/s10620-015-3630-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
437 Ren J, Liu S, Wang G, Gu G, Ren H, Hong Z, Li J. Laparoscopy improves clinical outcome of gastrointestinal fistula caused by Crohn's disease. J Surg Res 2016;200:110-6. [PMID: 26286894 DOI: 10.1016/j.jss.2015.07.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
438 Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK; International Multiple Sclerosis Genetics Consortium., International IBD Genetics Consortium. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015;47:979-86. [PMID: 26192919 DOI: 10.1038/ng.3359] [Cited by in Crossref: 1401] [Cited by in F6Publishing: 1472] [Article Influence: 175.1] [Reference Citation Analysis]
439 Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling KL, Ong D, Goh KL, Hilmi I, Ouyang Q, Wang YF, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B, Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M, Abdullah M, Tsang SW, Wong TC, Hui AJ, Chow CM, Yu HH, Li MF, Ng KK, Ching J, Wu JC, Chan FK, Sung JJ; Asia-Pacific Crohn's and Colitis Epidemiology Study ACCESS Group. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015;64:1063-71. [PMID: 25217388 DOI: 10.1136/gutjnl-2014-307410] [Cited by in Crossref: 225] [Cited by in F6Publishing: 261] [Article Influence: 28.1] [Reference Citation Analysis]
440 Lakatos PL, Burisch J. Environment and invironment in IBDs: partners in crime. Gut 2015;64:1009-10. [PMID: 25336112 DOI: 10.1136/gutjnl-2014-308460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
441 Bao CH, Liu P, Liu HR, Wu LY, Shi Y, Chen WF, Qin W, Lu Y, Zhang JY, Jin XM, Wang XM, Zhao JM, Liu XM, Tian J, Wu HG. Alterations in brain grey matter structures in patients with crohn's disease and their correlation with psychological distress. J Crohns Colitis 2015;9:532-40. [PMID: 25895879 DOI: 10.1093/ecco-jcc/jjv057] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
442 Taleban S. Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly. Curr Treat Options Gastro 2015;13:275-86. [DOI: 10.1007/s11938-015-0059-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
443 Leung WK. Optimization of Inflammatory Bowel Disease Cohort Studies in Asia. Intest Res 2015;13:208-12. [PMID: 26130994 DOI: 10.5217/ir.2015.13.3.208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
444 Hu PJ. Inflammatory Bowel Disease in Asia: The Challenges and Opportunities. Intest Res. 2015;13:188-190. [PMID: 26130991 DOI: 10.5217/ir.2015.13.3.188] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
445 News. Gastrointestinal Nursing 2015;13:6-10. [DOI: 10.12968/gasn.2015.13.5.6] [Reference Citation Analysis]
446 Chan WPW, Leow WQ. Ulcerative Colitis Diagnosed in a Patient after Primary Rectal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Treated. Proceedings of Singapore Healthcare 2015;24:123-129. [DOI: 10.1177/201010581502400210] [Reference Citation Analysis]
447 Taleban S, Colombel JF, Mohler MJ, Fain MJ. Inflammatory bowel disease and the elderly: a review. J Crohns Colitis 2015;9:507-15. [PMID: 25870198 DOI: 10.1093/ecco-jcc/jjv059] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 11.5] [Reference Citation Analysis]
448 Matsumoto T, Yanai S, Toya Y, Ueno M, Nakamura S. Internet-orientated Assessment of QOL and Actual Treatment Status in Japanese Patients with Inflammatory Bowel Disease: The 3I survey. J Crohns Colitis 2015;9:477-82. [PMID: 25814388 DOI: 10.1093/ecco-jcc/jjv052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
449 Wang F, Lin X, Zhao Q, Li J. Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis. Eur J Clin Pharmacol 2015;71:911-9. [PMID: 26022220 DOI: 10.1007/s00228-015-1877-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
450 Song Y, Shi YH, He C, Liu CQ, Wang JS, Zhao YJ, Guo YM, Wu RJ, Feng XY, Liu ZJ. Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis. World J Gastroenterol 2015; 21(19): 6082-6087 [PMID: 26019477 DOI: 10.3748/wjg.v21.i19.6082] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
451 Billiet T, Ferrante M, Van Assche G. The use of prognostic factors in inflammatory bowel diseases. Curr Gastroenterol Rep. 2014;16:416. [PMID: 25262067 DOI: 10.1007/s11894-014-0416-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
452 Chan D, Kumar D, Mendall M. What is known about the mechanisms of dietary influences in Crohn's disease? Nutrition 2015;31:1195-203. [PMID: 26333887 DOI: 10.1016/j.nut.2015.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
453 Randall CW, Vizuete JA, Martinez N, Alvarez JJ, Garapati KV, Malakouti M, Taboada CM. From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's disease. Therap Adv Gastroenterol 2015;8:143-59. [PMID: 25949527 DOI: 10.1177/1756283X15576462] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
454 Hart AL, Ng SC. Crohn's disease. Medicine 2015;43:282-90. [DOI: 10.1016/j.mpmed.2015.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
455 Hilmi I, Jaya F, Chua A, Heng WC, Singh H, Goh KL. A first study on the incidence and prevalence of IBD in Malaysia--results from the Kinta Valley IBD Epidemiology Study. J Crohns Colitis 2015;9:404-9. [PMID: 25744112 DOI: 10.1093/ecco-jcc/jjv039] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
456 de Silva P, Korzenik J. The changing epidemiology of inflammatory bowel disease: identifying new high-risk populations. Clin Gastroenterol Hepatol 2015;13:690-2. [PMID: 25451560 DOI: 10.1016/j.cgh.2014.11.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
457 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015;12:205-17. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 880] [Cited by in F6Publishing: 789] [Article Influence: 110.0] [Reference Citation Analysis]
458 Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50:495-507. [PMID: 25808229 DOI: 10.1007/s00535-015-1064-1] [Cited by in Crossref: 150] [Cited by in F6Publishing: 138] [Article Influence: 18.8] [Reference Citation Analysis]
459 Ghanadan A, Saghazadeh A, Jahanzad I, Rezaei N. Clinical aspects of indirect immunofluorescence for autoimmune diseases. Expert Rev Clin Immunol 2015;11:597-616. [PMID: 25786676 DOI: 10.1586/1744666X.2015.1027152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
460 Doh YS, Kim YS, Bae SI, Im JP, Cheon JH, Ye BD, Kim JW, Park YS, Lee JH, Kim YH, Kim JS, Han DS, Kim WH. The clinical characteristics of patients with free perforation in Korean Crohn's disease: results from the CONNECT study. BMC Gastroenterol 2015;15:31. [PMID: 25887913 DOI: 10.1186/s12876-015-0262-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
461 Li J, Wang F, Zhang HJ, Sheng JQ, Yan WF, Ma MX, Fan RY, Gu F, Li CF, Chen DF, Zheng P, Gu YP, Cao Q, Yang H, Qian JM, Hu PJ, Xia B. Corticosteroid therapy in ulcerative colitis: Clinical response and predictors. World J Gastroenterol 2015; 21(10): 3005-3015 [PMID: 25780299 DOI: 10.3748/wjg.v21.i10.3005] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
462 Ng SC. Emerging leadership lecture: Inflammatory bowel disease in Asia: emergence of a "Western" disease. J Gastroenterol Hepatol 2015;30:440-5. [PMID: 25469874 DOI: 10.1111/jgh.12859] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 8.6] [Reference Citation Analysis]
463 Parente JML, Coy CSR, Campelo V, Parente MPPD, Costa LA, Silva RMD, Stephan C, Zeitune JMR. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol 2015; 21(4): 1197-1206 [PMID: 25632193 DOI: 10.3748/wjg.v21.i4.1197] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
464 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 114] [Cited by in F6Publishing: 122] [Article Influence: 14.3] [Reference Citation Analysis]
465 Yang K, Tang ZP. Suppositories for treatment of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(36): 5648-5652 [DOI: 10.11569/wcjd.v22.i36.5648] [Reference Citation Analysis]
466 Alharbi OR, Azzam NA, Almalki AS, Almadi MA, Alswat KA, Sadaf N, Aljebreen AM. Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 2014; 20(46): 17525-17531 [PMID: 25516667 DOI: 10.3748/wjg.v20.i46.17525] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
467 Kaplan GG. IBD: Global variations in environmental risk factors for IBD. Nat Rev Gastroenterol Hepatol 2014;11:708-9. [PMID: 25348851 DOI: 10.1038/nrgastro.2014.182] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
468 Sales-Campos H, Basso PJ, Alves VB, Fonseca MT, Bonfá G, Nardini V, Cardoso CR. Classical and recent advances in the treatment of inflammatory bowel diseases. Braz J Med Biol Res. 2015;48:96-107. [PMID: 25466162 DOI: 10.1590/1414-431x20143774] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
469 Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: A comparison of Eastern and Western perspectives. World J Gastroenterol 2014; 20(33): 11525-11537 [PMID: 25206259 DOI: 10.3748/wjg.v20.i33.11525] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 81] [Article Influence: 8.1] [Reference Citation Analysis]
470 Ng SC, Hirai HW, Tsoi KK, Wong SH, Chan FK, Sung JJ, Wu JC. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians. J Gastroenterol Hepatol 2014;29:1664-70. [PMID: 24910240 DOI: 10.1111/jgh.12645] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
471 da Silva BC, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol 2014;20:9458-67. [PMID: 25071340 DOI: 10.3748/wjg.v20.i28.9458] [Cited by in CrossRef: 154] [Cited by in F6Publishing: 160] [Article Influence: 17.1] [Reference Citation Analysis]
472 Zhiqin W, Palaniappan S, Raja Ali RA. Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res 2014;12:194-204. [PMID: 25349593 DOI: 10.5217/ir.2014.12.3.194] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
473 Li Y, Tian Y, Zhu W, Gong J, Gu L, Zhang W, Guo Z, Li N, Li J. Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol 2014;49:834-44. [PMID: 24940636 DOI: 10.3109/00365521.2014.910834] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
474 Xu S, Zhou F, Tao J, Song L, Ng SC, Wang X, Chen L, Yi F, Ran Z, Zhou R. Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn’s disease in a Chinese family study. PLoS One. 2014;9:e99807. [PMID: 24937328 DOI: 10.1371/journal.pone.0099807] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
475 Timm S, Svanes C, Janson C, Sigsgaard T, Johannessen A, Gislason T, Jogi R, Omenaas E, Forsberg B, Torén K. Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe. Eur J Epidemiol. 2014;29:429-437. [PMID: 24916994 DOI: 10.1007/s10654-014-9922-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
476 Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol 2014;28:363-72. [PMID: 24913377 DOI: 10.1016/j.bpg.2014.04.003] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 10.7] [Reference Citation Analysis]
477 Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol 2014;11:372-85. [PMID: 24614343 DOI: 10.1038/nrgastro.2014.27] [Cited by in Crossref: 99] [Cited by in F6Publishing: 82] [Article Influence: 11.0] [Reference Citation Analysis]
478 Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35:347-369. [PMID: 24793874 DOI: 10.1016/j.yfrne.2014.04.004] [Cited by in Crossref: 486] [Cited by in F6Publishing: 511] [Article Influence: 54.0] [Reference Citation Analysis]
479 Yang Y, Tomkovich S, Jobin C. Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish. Inflamm Bowel Dis 2014;20:956-66. [PMID: 24577115 DOI: 10.1097/01.MIB.0000442923.85569.68] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
480 Kim SB, Park SJ, Chung SH, Hahn KY, Moon DC, Hong SP, Cheon JH, Kim TI, Kim WH. Vaccination and complementary and alternative medicine in patients with inflammatory bowel disease. Intest Res 2014;12:124-30. [PMID: 25349579 DOI: 10.5217/ir.2014.12.2.124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
481 Lei P, Gu F, Hong L, Sun Y, Li M, Wang H, Zhong B, Chen M, Cui Y, Zhang S. Pediatric colonoscopy in South China: a 12-year experience in a tertiary center. PLoS One 2014;9:e95933. [PMID: 24759776 DOI: 10.1371/journal.pone.0095933] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
482 Golovics PA, Mandel MD, Lovasz BD, Lakatos PL. Inflammatory bowel disease course in Crohn’s disease: Is the natural history changing? World J Gastroenterol 2014; 20(12): 3198-3207 [PMID: 24696605 DOI: 10.3748/wjg.v20.i12.3198] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
483 Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014;49:785-798. [PMID: 24652102 DOI: 10.1007/s00535-014-0953-z] [Cited by in Crossref: 141] [Cited by in F6Publishing: 148] [Article Influence: 15.7] [Reference Citation Analysis]
484 Ghosh S. Ulcerative colitis--what can we learn from the Asia-Pacific region? Can J Gastroenterol Hepatol 2014;28:122. [PMID: 24619630 DOI: 10.1155/2014/834909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
485 Zhou M, Wang Z, Chen J, Zhan Y, Wang T, Xia L, Wang S, Hua Z, Zhang J. Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice. Br J Nutr 2014;111:1822-9. [PMID: 24480400 DOI: 10.1017/S000711451300442X] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
486 Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini F, Salvarani C, Girolomoni G. The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases. Int J Immunopathol Pharmacol 2014;27:1-10. [DOI: 10.1177/03946320140270s101] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
487 Gasparetto M, Guariso G. Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age. Gastroenterol Res Pract. 2013;2013:829040. [PMID: 24454343 DOI: 10.1155/2013/829040] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
488 Vanuytsel T, Vermeire S, Cleynen I. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers. 2013;1:e27321. [PMID: 24868498 DOI: 10.4161/tisb.27321] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 8.9] [Reference Citation Analysis]
489 Wei SC, Lin MH, Tung CC, Weng MT, Kuo JS, Shieh MJ, Wang CY, Ho WC, Wong JM, Chen PC. A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol. 2013;13:166. [PMID: 24314308 DOI: 10.1186/1471-230x-13-166] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
490 Chuang CH, Lin SH, Chen CY, Sheu BS, Kao AW, Wang JD. Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010. Inflamm Bowel Dis 2013;19:2815-9. [PMID: 24141711 DOI: 10.1097/01.MIB.0000435436.99612.27] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
491 Carroll IM, Maharshak N. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications. World J Gastroenterol 2013; 19(43): 7531-7543 [PMID: 24431894 DOI: 10.3748/wjg.v19.i43.7531] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
492 Ye L, Cao Q, Cheng J. Review of inflammatory bowel disease in China. ScientificWorldJournal. 2013;2013:296470. [PMID: 24348149 DOI: 10.1155/2013/296470] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
493 Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013;145:970-7. [PMID: 23912083 DOI: 10.1053/j.gastro.2013.07.050] [Cited by in Crossref: 367] [Cited by in F6Publishing: 366] [Article Influence: 36.7] [Reference Citation Analysis]
494 Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I. Inflammatory bowel disease serology in Asia and the West. World J Gastroenterol 2013; 19(37): 6207-6213 [PMID: 24115818 DOI: 10.3748/wjg.v19.i37.6207] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
495 Qin X. Is the gap between the developed and developing countries in the incidence of inflammatory bowel disease disappearing? Gastroenterology 2013;145:912. [PMID: 23973855 DOI: 10.1053/j.gastro.2013.07.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
496 Ng SC. Reply: To PMID 23583432. Gastroenterology 2013;145:912. [PMID: 23973856 DOI: 10.1053/j.gastro.2013.08.045] [Reference Citation Analysis]
497 Abdullah M, Syam AF, Simadibrata M, Gunawan J, Makmun D, Rani AA. New insights on the pathomechanisms of inflammatory bowel disease. J Dig Dis 2013;14:455-62. [PMID: 23764259 DOI: 10.1111/1751-2980.12081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
498 Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2014;345:235-241. [PMID: 23941831 DOI: 10.1016/j.canlet.2013.07.032] [Cited by in Crossref: 177] [Cited by in F6Publishing: 198] [Article Influence: 17.7] [Reference Citation Analysis]
499 Yamagami H, Watanabe K, Kamata N, Sogawa M, Arakawa T. Small bowel endoscopy in inflammatory bowel disease. Clin Endosc. 2013;46:321-326. [PMID: 23964328 DOI: 10.5946/ce.2013.46.4.321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]